,Unnamed: 0,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af
0,0,1,M,R,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1,1,1,M,T,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
2,2,1,M,V,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
3,3,2,E,K,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021, skcm_tcga, skcm_tcga_pan_can_atlas_2018","Breast, Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14014026-14014026, hg38,16:13920169-13920169","hg19,16:g.14014026G>A, hg38,16:g.13920169G>A",0.103,"breast, skin","carcinoma, lobular_carcinoma, malignant_melanoma",,,,
4,4,2,E,Q,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
5,5,3,S,L,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_2), 1-3, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
6,6,4,G,A,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_mskcc_2020, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14014033-14014033, hg38,16:13920176-13920176","hg19,16:g.14014033G>C, hg38,16:g.13920176G>C",0.091,lung,"carcinoma, adenocarcinoma",,,,
7,7,4,G,E,,,,,,,,,,,,,cBioPortal,skcm_dfci_2015,Cutaneous Melanoma,"hg19,16:14014033-14014033","hg19,16:g.14014033G>A",0.033,,,,,,
8,8,5,Q,,,,,,,,,,,,,,,,,,,,,,,,,
9,9,6,P,L,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv","luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14014039-14014039","hg19,16:g.14014039C>T",0.032,,,,,,
10,10,6,P,Q,,,,,,,,,,,,,cBioPortal,luad_oncosg_2020,Lung Adenocarcinoma,"hg19,16:14014039-14014039","hg19,16:g.14014039C>A",0.012,,,,,,
11,11,6,P,S,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",blca_bcan_hcrn_2022,Bladder Urothelial Carcinoma,"hg19,16:14014038-14014038","hg19,16:g.14014038C>T",0.298,,,0.0004584276345134,0.0005097489486428,,
12,12,7,A,T,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
13,13,7,A,V,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
14,14,8,R,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 8-10, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 8-10, ELM",,"cBioPortal,COSMIC",gbm_tcga_pan_can_atlas_2018,Glioblastoma Multiforme,"hg19,16:14014045-14014045, hg38,16:13920188-13920188","hg19,16:g.14014045G>T, hg38,16:g.13920188G>T",0.089,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
15,15,9,R,G,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 8-10, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 8-10, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
16,16,9,R,P,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 8-10, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 8-10, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
17,17,9,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 8-10, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 8-10, ELM",,"cBioPortal,COSMIC","hnc_mskcc_2016, msk_impact_2017, msk_met_2021","Head and Neck, Mixed Cancer Types","hg19,16:14014047-14014047, hg38,16:13920190-13920190","hg19,16:g.14014047C>T, hg38,16:g.13920190C>T",0.141,skin,"carcinoma, squamous_cell_carcinoma",4.1144813285e-06,,,
18,18,10,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 8-10, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 8-10, ELM",,,,,,,,,,,,,
19,19,11,A,S,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,"cBioPortal,COSMIC",mixed_allen_2018,Mixed Cancer Types,"hg19,16:14014053-14014053, hg38,16:13920196-13920196","hg19,16:g.14014053G>T, hg38,16:g.13920196G>T",0.051,lung,"carcinoma, non_small_cell_carcinoma",4.1039783967e-06,,,
20,20,11,A,V,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
21,21,12,M,T,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,16:14014057-14014057, hg38,16:13920200-13920200","hg19,16:g.14014057T>C, hg38,16:g.13920200T>C",0.274,lung,"carcinoma, squamous_cell_carcinoma",,,,
22,22,12,M,V,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
23,23,13,A,S,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
24,24,13,A,T,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,16:14014059-14014059","hg19,16:g.14014059G>A",0.197,,,3.27723794386e-05,3.18613394507e-05,,
25,25,14,P,L,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
26,26,14,P,R,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
27,27,14,P,S,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:14014062-14014062, hg38,16:13920205-13920205","hg19,16:g.14014062C>T, hg38,16:g.13920205C>T",0.124,large_intestine,"carcinoma, adenocarcinoma",,,,
28,28,15,L,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,,,,,,,,,,,,
29,29,16,L,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 11-16, ELM",,,,,,,,,,,,,
30,30,17,E,G,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM",,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,16:14014072-14014072","hg19,16:g.14014072A>G",0.429,,,,,,
31,31,17,E,Q,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14014071-14014071","hg19,16:g.14014071G>C",0.180,,,4.0856682928e-06,,,
32,32,18,Y,S,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 18-22, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 18-21, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14014075-14014075","hg19,16:g.14014075A>C",0.383,,,,,,
33,33,19,E,K,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 18-22, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 18-21, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14014077-14014077","hg19,16:g.14014077G>A",0.462,,,,,,
34,34,20,R,Q,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 18-22, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 18-21, ELM",,cBioPortal,glioma_mskcc_2019,Diffuse Glioma,"hg19,16:14014081-14014081","hg19,16:g.14014081G>A",0.139,,,,,,
35,35,21,Q,E,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 18-22, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 18-21, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13920226-13920226","hg38,16:g.13920226C>G",0.070,"large_intestine, rectum","carcinoma, adenocarcinoma",4.0785695641e-06,3.18552497452e-05,,
36,36,21,Q,H,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 18-22, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 18-21, ELM",,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,16:14014085-14014085","hg19,16:g.14014085G>C",0.219,,,2.0394012318e-05,,,
37,37,21,Q,L,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 18-22, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 18-21, ELM",,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,16:14014084-14014084","hg19,16:g.14014084A>T",0.323,,,,,,
38,38,22,L,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 18-22, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,,,,,,,,,,,,
39,39,23,V,M,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,cBioPortal,prad_pik3r1_msk_2021,Prostate Adenocarcinoma,"hg19,16:14014089-14014089","hg19,16:g.14014089G>A",0.167,,,,,,
40,40,24,L,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,,,,,,,,,,,,
41,41,25,E,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,,,,,,,,,,,,
42,42,26,L,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,,,,,,,,,,,,
43,43,27,L,F,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",bowel_colitis_msk_2022,Bowel,"hg19,16:14014101-14014101","hg19,16:g.14014101C>T",0.048,,,2.03931805204e-05,3.18451054073e-05,,
44,44,27,L,P,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,cBioPortal,blca_msk_tcga_2020,Bladder Urothelial Carcinoma,"hg19,16:14014102-14014102","hg19,16:g.14014102T>C",0.438,,,,,,
45,45,27,L,R,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,COSMIC,,,"hg38,16:13920245-13920245","hg38,16:g.13920245T>G",0.296,"central_nervous_system, brain","glioma, oligodendroglioma",,,,
46,46,27,L,V,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,COSMIC,,,"hg38,16:13920244-13920244","hg38,16:g.13920244C>G",0.066,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,
47,47,28,D,H,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 17-28, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,COSMIC,,,"hg38,16:13920247-13920247","hg38,16:g.13920247G>C",0.034,breast,"carcinoma, ductal_carcinoma",,,,
48,48,29,T,I,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 29-34, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
49,49,30,D,A,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 29-34, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 30-34, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
50,50,30,D,G,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 29-34, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 30-34, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 22-30, ELM",,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_met_2021, nsclc_ctdx_msk_2022, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14014111-14014111","hg19,16:g.14014111A>G",0.611,,,,,,
51,51,31,G,R,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 29-34, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 30-34, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
52,52,32,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 29-34, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 30-34, ELM",,,,,,,,,,,,,
53,53,33,V,A,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 27-33, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 29-34, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 30-34, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
54,54,34,V,M,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_LC3C_4), 29-34, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 30-34, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
55,55,35,C,,,,,,,,,,,,,,,,,,,,,,,,,
56,56,36,A,D,,,,,,,,,,,,,cBioPortal,"esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,16:14014129-14014129","hg19,16:g.14014129C>A",0.600,,,,,,
57,57,36,A,P,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
58,58,36,A,S,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14014128-14014128","hg19,16:g.14014128G>T",0.317,,,,,,
59,59,36,A,T,,,,,,,,,,,,,cBioPortal,"blca_bcan_hcrn_2022, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,16:14014128-14014128","hg19,16:g.14014128G>A",0.545,,,,,,
60,60,37,R,C,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
61,61,37,R,H,,,,,,,,,,,,,COSMIC,,,"hg38,16:13920275-13920275","hg38,16:g.13920275G>A",0.229,thyroid,carcinoma,,,,
62,62,38,G,,,,,,,,,,,,,,,,,,,,,,,,,
63,63,39,L,,,,,,,,,,,,,,,,,,,,,,,,,
64,64,40,G,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 40-45, ELM",,,,,,,,,,,,,
65,65,41,A,G,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 40-45, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
66,66,42,D,G,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 40-45, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
67,67,42,D,N,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 40-45, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
68,68,43,R,W,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 40-45, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
69,69,44,L,F,,,,,,,,,,,"Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 44-49, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 40-45, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
70,70,45,L,,,,,,,,,,,,"Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 44-49, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 40-45, ELM",,,,,,,,,,,,,
71,71,46,Y,C,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 46-50, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 44-49, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 46-49, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
72,72,47,H,P,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 46-50, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 44-49, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 46-49, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:14014162-14014162","hg19,16:g.14014162A>C",0.170,,,,,,
73,73,48,F,L,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 46-50, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 44-49, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 46-49, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:14014166-14014166","hg19,16:g.14014166T>A",0.099,,,,,,
74,74,48,F,Y,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 46-50, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 44-49, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 46-49, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
75,75,49,L,F,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 46-50, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 44-49, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 46-49, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",acc_2019,Adenoid Cystic Carcinoma,"hg19,16:14014167-14014167","hg19,16:g.14014167C>T",0.419,,,2.9537859096e-05,3.18613394507e-05,,
76,76,49,L,I,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 46-50, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 44-49, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 46-49, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:14014167-14014167, hg38,16:13920310-13920310","hg19,16:g.14014167C>A, hg38,16:g.13920310C>A",0.102,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
77,77,50,Q,R,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 46-50, ELM",,cBioPortal,coadread_mskresistance_2022,Colorectal Adenocarcinoma,"hg19,16:14014163-14014175","hg19,16:g.14014163_14014175delinsTTTCCTGCGGCTT",,,,,,,
78,78,51,L,,,,,,,,,,,,,,,,,,,,,,,,,
79,79,52,H,,,,,,,,,,,,,,,,,,,,,,,,,
80,80,53,C,F,,,,,,,,,,,,,cBioPortal,"msk_met_2021, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,16:14014180-14014180","hg19,16:g.14014180G>T",0.241,,,,,,
81,81,54,H,R,,,,,,,,,,,,,cBioPortal,crc_nigerian_2020,Colorectal Adenocarcinoma,"hg19,16:14014183-14014183","hg19,16:g.14014183A>G",0.144,,,,,,
82,82,55,P,A,,,,,,,,,,,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,16:14014185-14014185","hg19,16:g.14014185C>G",0.097,,,,,,
83,83,56,A,V,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
84,84,57,C,S,,,,,,,,,,,,,cBioPortal,"crc_dd_2022, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14014191-14014191","hg19,16:g.14014191T>A",0.094,,,,,,
85,85,58,L,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 58-64, ELM",,,,,,,,,,,,,
86,86,59,V,E,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 58-64, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
87,87,60,L,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 58-64, ELM",,,,,,,,,,,,,
88,88,61,V,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 58-64, ELM",,,,,,,,,,,,,
89,89,62,L,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 58-64, ELM",,,,,,,,,,,,,
90,90,63,N,H,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 58-64, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
91,91,64,T,M,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 58-64, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14014213-14014213","hg19,16:g.14014213C>T",0.305,,,,,,
92,92,65,Q,K,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14014215-14014215, hg38,16:13920358-13920358","hg19,16:g.14014215C>A, hg38,16:g.13920358C>A",0.050,,malignant_melanoma,,,,
93,93,65,Q,L,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
94,94,66,P,Q,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 66-69, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM",,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,16:14014219-14014219","hg19,16:g.14014219C>A",0.050,,,,,,
95,95,66,P,T,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 66-69, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM",,COSMIC,,,"hg38,16:13920361-13920361","hg38,16:g.13920361C>A",0.069,prostate,carcinoma,,,,
96,96,67,A,T,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 66-69, ELM|TRAF2 binding site (LIG_TRAF2_1), 67-70, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14014221-14014221, hg38,16:13920364-13920364","hg19,16:g.14014221G>A, hg38,16:g.13920364G>A",0.081,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,,,
97,97,68,E,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 66-69, ELM|TRAF2 binding site (LIG_TRAF2_1), 67-70, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14014224-14014224","hg19,16:g.14014224G>A",0.660,,,,,,
98,98,69,E,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 66-69, ELM|TRAF2 binding site (LIG_TRAF2_1), 67-70, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,,,,,,,,,,,,
99,99,70,E,G,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 67-70, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,"cBioPortal,COSMIC","kirc_tcga, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,16:14015889-14015889, hg38,16:13922032-13922032","hg19,16:g.14015889A>G, hg38,16:g.13922032A>G",0.408,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,
100,100,70,E,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 67-70, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,16:14015888-14015888, hg38,16:13922031-13922031","hg19,16:g.14015888G>A, hg38,16:g.13922031G>A",0.312,cervix,"carcinoma, squamous_cell_carcinoma",,,,
101,101,71,Y,C,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 71-74, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,16:14015892-14015892, hg38,16:13922035-13922035","hg19,16:g.14015892A>G, hg38,16:g.13922035A>G",0.687,"large_intestine, colon, ascending, small_intestine, ileum","carcinoma, adenocarcinoma",,,,
102,102,71,Y,H,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 71-74, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
103,103,72,F,L,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 71-74, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 64-72, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
104,104,73,I,V,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 71-74, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_2), 67-73, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13922040-13922040","hg38,16:g.13922040A>G",0.118,prostate,carcinoma,0.0002229370362113,0.0001911193221635,,
105,105,74,N,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 71-74, ELM",,,,,,,,,,,,,
106,106,75,Q,,,,,,,,,,,,,,,,,,,,,,,,,
107,107,76,L,,,,,,,,,,,,,,,,,,,,,,,,,
108,108,77,K,,,,,,,,,,,,,,,,,,,,,,,,,
109,109,78,I,L,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
110,110,78,I,T,,,,,,,,,,,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14015913-14015913, hg38,16:13922056-13922056","hg19,16:g.14015913T>C, hg38,16:g.13922056T>C",0.081,thyroid,"carcinoma, papillary_carcinoma",1.59150771483e-05,,,
111,111,79,E,G,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14015916-14015916","hg19,16:g.14015916A>G",0.189,,,,,,
112,112,79,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14015915-14015915, hg38,16:13922058-13922058","hg19,16:g.14015915G>A, hg38,16:g.13922058G>A",0.187,"lung, right_upper_lobe","carcinoma, adenocarcinoma",3.9792442619e-06,,,
113,113,80,G,E,,,,,,,,,,,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:14015919-14015919, hg38,16:13922062-13922062","hg19,16:g.14015919G>A, hg38,16:g.13922062G>A",0.129,oesophagus,"carcinoma, squamous_cell_carcinoma",3.9789592634e-06,,,
114,114,80,G,R,,,,,,,,,,,,,COSMIC,,,"hg38,16:13922061-13922061","hg38,16:g.13922061G>A",0.283,large_intestine,"carcinoma, adenocarcinoma",,3.18552497452e-05,,
115,115,81,V,F,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
116,116,81,V,I,,,,,,,,,,,,,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13922064-13922064","hg38,16:g.13922064G>A",0.107,lung,"carcinoma, non_small_cell_carcinoma",5.96820142282e-05,0.0002548744743214,,
117,117,82,E,,,,,,,,,,,,,,,,,,,,,,,,,
118,118,83,H,,,,,,,,,,,,,,,,,,,,,,,,,
119,119,84,L,F,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
120,120,85,P,,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 85-87, ELM",,,,,,,,,,,,,
121,121,86,R,C,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 86-88, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 85-87, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 86-88, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
122,122,86,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 86-88, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 85-87, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 86-88, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,16:14015937-14015937, hg38,16:13922080-13922080","hg19,16:g.14015937G>A, hg38,16:g.13922080G>A",0.159,breast,"carcinoma, ductal_carcinoma",0.0001472449280092,9.56632653061e-05,,
123,123,86,R,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 86-88, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 85-87, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 86-88, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14015937-14015937, hg38,16:13922080-13922080","hg19,16:g.14015937G>T, hg38,16:g.13922080G>T",0.131,lung,"carcinoma, adenocarcinoma",,,,
124,124,86,R,S,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 86-88, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 85-87, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 86-88, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:14015936-14015936, hg38,16:13922079-13922079","hg19,16:g.14015936C>A, hg38,16:g.13922079C>A",0.183,skin,malignant_melanoma,,,,
125,125,87,R,C,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 86-88, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 85-87, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 86-88, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13922082-13922082","hg38,16:g.13922082C>T",0.207,"large_intestine, rectum","carcinoma, adenocarcinoma",1.98973297783e-05,,,
126,126,87,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 86-88, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 85-87, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 86-88, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv","angs_painter_2020, angs_project_painter_2018, coad_silu_2022, gbc_msk_2018, msk_met_2021","Angiosarcoma, Colon Adenocarcinoma, Gallbladder Cancer, Mixed Cancer Types","hg19,16:14015940-14015940","hg19,16:g.14015940G>A",0.159,,,8.35761020106e-05,0.0001274697259401,,
127,127,87,R,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 86-88, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 85-87, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 86-88, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14015940-14015940","hg19,16:g.14015940G>T",0.099,,,,,,
128,128,88,V,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 86-88, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 86-88, ELM",,cBioPortal,"msk_met_2021, nsclc_ctdx_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14015942-14015942","hg19,16:g.14015942G>C",0.256,,,,,,
129,129,89,T,K,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14015946-14015946","hg19,16:g.14015946C>A",0.421,,,,,,
130,130,90,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 86-90, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM",,,,,,,,,,,,,
131,131,91,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM",,,,,,,,,,,,,
132,132,92,I,S,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
133,133,93,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 87-93, ELM",,,,,,,,,,,,,
134,134,94,S,,,,,,,,,,,,,,,,,,,,,,,,,
135,135,95,N,K,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:14015965-14015965","hg19,16:g.14015965C>A",0.030,,,3.978167815e-06,,,
136,136,96,S,R,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
137,137,97,R,C,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14015969-14015969","hg19,16:g.14015969C>T",0.858,,,1.19353581005e-05,3.18572793883e-05,,
138,138,97,R,H,,,,,,,,,,,,,"cBioPortal,COSMIC","acc_2019, msk_met_2021","Adenoid Cystic Carcinoma, Mixed Cancer Types","hg19,16:14015970-14015970, hg38,16:13922113-13922113","hg19,16:g.14015970G>A, hg38,16:g.13922113G>A",0.884,endometrium,"carcinoma, endometrioid_carcinoma",1.59144439493e-05,,,
139,139,97,R,L,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14015970-14015970, hg38,16:13922113-13922113","hg19,16:g.14015970G>T, hg38,16:g.13922113G>T",0.926,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,,,
140,140,98,Y,C,,,,,,,,,,,,,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,16:14015973-14015973","hg19,16:g.14015973A>G",0.364,,,,,,
141,141,99,E,A,,,,,,,,,,,,,COSMIC,,,"hg38,16:13922119-13922119","hg38,16:g.13922119A>C",0.133,lung,"carcinoma, non_small_cell_carcinoma",,,,
142,142,100,V,,,,,,,,,,,,,,,,,,,,,,,,,
143,143,101,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 101-104, ELM",,,,,,,,,,,,,
144,144,102,T,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 101-104, ELM",,,,,,,,,,,,,
145,145,103,Q,E,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 101-104, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,16:14015987-14015987, hg38,16:13922130-13922130","hg19,16:g.14015987C>G, hg38,16:g.13922130C>G",0.061,liver,carcinoma,,,,
146,146,104,G,C,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 101-104, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:14015990-14015990, hg38,16:13922133-13922133","hg19,16:g.14015990G>T, hg38,16:g.13922133G>T",0.860,skin,malignant_melanoma,,,,
147,147,104,G,R,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 101-104, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14015990-14015990","hg19,16:g.14015990G>C",0.795,,,,,,
148,148,105,G,R,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
149,149,106,V,G,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
150,150,107,I,L,,,,,,,,,,,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,16:14015999-14015999, hg38,16:13922142-13922142","hg19,16:g.14015999A>T, hg38,16:g.13922142A>T",0.087,liver,carcinoma,3.9788009485e-06,,,
151,151,107,I,M,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
152,152,108,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM",,,,,,,,,,,,,
153,153,109,A,T,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
154,154,109,A,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,16:14016006-14016006, hg38,16:13922149-13922149","hg19,16:g.14016006C>T, hg38,16:g.13922149C>T",0.068,stomach,"carcinoma, adenocarcinoma",1.19393481116e-05,,,
155,155,110,T,I,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM",,"cBioPortal,COSMIC","blca_nmibc_2017, msk_impact_2017, msk_met_2021, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14016009-14016009, hg38,16:13922152-13922152","hg19,16:g.14016009C>T, hg38,16:g.13922152C>T",0.692,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,
156,156,111,S,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 111-116, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM",,,,,,,,,,,,,
157,157,112,R,K,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 111-116, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 112-117, ELM",,cBioPortal,"msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14016015-14016015","hg19,16:g.14016015G>A",0.812,,,,,,
158,158,112,R,S,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 111-116, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 112-117, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
159,159,113,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 111-116, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 112-117, ELM",,,,,,,,,,,,,
160,160,114,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 108-114, ELM|Atg8 protein family ligands (LIG_LIR_LC3C_4), 111-116, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 112-117, ELM",,,,,,,,,,,,,
161,161,115,V,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_LC3C_4), 111-116, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 112-117, ELM",,,,,,,,,,,,,
162,162,116,V,F,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_LC3C_4), 111-116, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 112-117, ELM",,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14016026-14016026","hg19,16:g.14016026G>T",0.849,,,,,,
163,163,116,V,I,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_LC3C_4), 111-116, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 112-117, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",acc_2019,Adenoid Cystic Carcinoma,"hg19,16:14016026-14016026","hg19,16:g.14016026G>A",0.425,,,7.56411583448e-05,6.37145587767e-05,,
164,164,117,D,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 110-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 111-117, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 112-117, ELM",,,,,,,,,,,,,
165,165,118,F,L,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 118-124, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:14016034-14016034, hg38,16:13922177-13922177","hg19,16:g.14016034C>A, hg38,16:g.13922177C>A",0.217,endometrium,"carcinoma, endometrioid_carcinoma",,,,
166,166,119,L,F,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 118-124, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14016037-14016037, hg38,16:13922180-13922180","hg19,16:g.14016037G>T, hg38,16:g.13922180G>T",0.737,"central_nervous_system, cerebellum","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
167,167,120,T,I,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 118-124, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14016039-14016039, hg38,16:13922182-13922182","hg19,16:g.14016039C>T, hg38,16:g.13922182C>T",0.289,endometrium,"carcinoma, endometrioid_carcinoma",,,,
168,168,121,D,G,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 118-124, ELM",,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,16:14016042-14016042, hg38,16:13922185-13922185","hg19,16:g.14016042A>G, hg38,16:g.13922185A>G",0.188,liver,"carcinoma, hepatocellular_carcinoma",,,,
169,169,122,R,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 118-124, ELM",,,,,,,,,,,,,
170,170,123,I,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 118-124, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
171,171,124,P,H,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 118-124, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14016051-14016051","hg19,16:g.14016051C>A",0.783,,,,,,
172,172,125,S,,,,,,,,,,,,,,,,,,,,,,,,,
173,173,126,D,H,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
174,174,126,D,V,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
175,175,127,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 127-133, ELM",,,,,,,,,,,,,
176,176,128,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 127-133, ELM",,,,,,,,,,,,,
177,177,129,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 127-133, ELM",,,,,,,,,,,,,
178,178,130,G,C,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 127-133, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:14016068-14016068, hg38,16:13922211-13922211","hg19,16:g.14016068G>T, hg38,16:g.13922211G>T",0.875,skin,malignant_melanoma,,,,
179,179,130,G,D,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 127-133, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:14020418-14020418, hg38,16:13926561-13926561","hg19,16:g.14020418G>A, hg38,16:g.13926561G>A",0.884,stomach,"carcinoma, adenocarcinoma",,,,
180,180,131,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 127-133, ELM",,,,,,,,,,,,,
181,181,132,L,F,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 127-133, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13926568-13926568","hg38,16:g.13926568G>T",0.266,placenta,choriocarcinoma,3.9767440011e-06,9.55535737037e-05,,
182,182,133,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 127-133, ELM",,,,,,,,,,,,,
183,183,134,Y,C,,,,,,,,,,,,,COSMIC,,,"hg38,16:13926573-13926573","hg38,16:g.13926573A>G",0.615,breast,"carcinoma, ductal_carcinoma",3.9766174892e-06,,,
184,184,135,R,K,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
185,185,135,R,T,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14020433-14020433, hg38,16:13926576-13926576","hg19,16:g.14020433G>C, hg38,16:g.13926576G>C",0.570,lung,"carcinoma, adenocarcinoma",3.9768388903e-06,,,
186,186,136,A,T,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14020435-14020435, hg38,16:13926578-13926578","hg19,16:g.14020435G>A, hg38,16:g.13926578G>A",0.878,lung,"carcinoma, adenocarcinoma",,,,
187,187,137,H,D,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
188,188,137,H,Y,,,,,,,,,,,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14020438-14020438","hg19,16:g.14020438C>T",0.848,,,,,,
189,189,138,R,K,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,16:14020442-14020442, hg38,16:13926585-13926585","hg19,16:g.14020442G>A, hg38,16:g.13926585G>A",0.078,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,
190,190,139,I,,,,,,,,,,,,,,,,,,,,,,,,,
191,191,140,I,,,,,,,,,,,,,,,,,,,,,,,,,
192,192,141,E,K,,,,,,,,,,,,,cBioPortal,acc_2019,Adenoid Cystic Carcinoma,"hg19,16:14020450-14020450","hg19,16:g.14020450G>A",0.523,,,1.98840363003e-05,,,
193,193,142,S,Y,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 142-145, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14020454-14020454","hg19,16:g.14020454C>A",0.632,,,1.19302320032e-05,6.36942675159e-05,,
194,194,143,C,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 142-145, ELM",,,,,,,,,,,,,
195,195,144,Q,R,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 142-145, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
196,196,145,E,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 142-145, ELM",,,,,,,,,,,,,
197,197,146,A,S,,,,,,,,,,,,,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,16:14020465-14020465","hg19,16:g.14020465G>T",0.311,,,,,,
198,198,147,F,,,,,,,,,,,,,,,,,,,,,,,,,
199,199,148,I,T,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14020472-14020472, hg38,16:13926615-13926615","hg19,16:g.14020472T>C, hg38,16:g.13926615T>C",0.616,endometrium,"carcinoma, endometrioid_carcinoma",,,,
200,200,149,L,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,,,,,,,,,,,,
201,201,150,R,C,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","coad_silu_2022, msk_met_2021, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_tcga_pan_can_atlas_2018","Colon Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,16:14020477-14020477, hg38,16:13926620-13926620","hg19,16:g.14020477C>T, hg38,16:g.13926620C>T",0.893,"endometrium, large_intestine, lung, stomach","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",1.1930137117e-05,3.18552497452e-05,,
202,202,150,R,H,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_met_2021, rectal_msk_2019","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14020478-14020478, hg38,16:13926621-13926621","hg19,16:g.14020478G>A, hg38,16:g.13926621G>A",0.877,"large_intestine, rectum","carcinoma, adenocarcinoma",7.9533614882e-06,3.18593092902e-05,,
203,203,151,L,F,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
204,204,152,F,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,,,,,,,,,,,,
205,205,153,R,C,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","crc_apc_impact_2020, crc_msk_2017",Colorectal Adenocarcinoma,"hg19,16:14020486-14020486, hg38,16:13926629-13926629","hg19,16:g.14020486C>T, hg38,16:g.13926629C>T",0.845,"biliary_tract, bile_duct, large_intestine, colon, sigmoid","carcinoma, carcinoma, adenocarcinoma",3.9768388903e-06,3.186336987e-05,,
206,206,153,R,H,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14020487-14020487","hg19,16:g.14020487G>A",0.901,,,2.38606537819e-05,,,
207,207,153,R,L,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,16:14020487-14020487, hg38,16:13926630-13926630","hg19,16:g.14020487G>T, hg38,16:g.13926630G>T",0.895,ovary,"carcinoma, serous_carcinoma",3.9767756303e-06,,,
208,208,153,R,P,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","breast_msk_2018, msk_impact_2017","Breast, Mixed Cancer Types","hg19,16:14020487-14020487, hg38,16:13926630-13926630","hg19,16:g.14020487G>C, hg38,16:g.13926630G>C",0.919,breast,"carcinoma, carcinoma, HER-positive_carcinoma",3.9767756303e-06,,,
209,209,154,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,,,,,,,,,,,,
210,210,155,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 148-155, ELM",,,,,,,,,,,,,
211,211,156,N,S,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14020496-14020496, hg38,16:13926639-13926639","hg19,16:g.14020496A>G, hg38,16:g.13926639A>G",0.636,endometrium,"carcinoma, endometrioid_carcinoma",,,,
212,212,157,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 157-159, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM",,,,,,,,,,,,,
213,213,158,R,C,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 157-159, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,16:14020501-14020501, hg38,16:13926644-13926644","hg19,16:g.14020501C>T, hg38,16:g.13926644C>T",0.088,liver,carcinoma,7.9535512606e-06,3.1849162367e-05,,
214,214,158,R,H,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 157-159, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","luad_mskcc_2023_met_organotropism, luad_mskimpact_2021, lung_msk_2017, msk_impact_2017","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14020502-14020502, hg38,16:13926645-13926645","hg19,16:g.14020502G>A, hg38,16:g.13926645G>A",0.059,lung,"carcinoma, adenocarcinoma",1.59071025213e-05,,,
215,215,159,G,D,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 157-159, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
216,216,159,G,S,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 157-159, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 153-159, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
217,217,160,F,,,,,,,,,,,,"Pex14 ligand motif (LIG_Pex14_2), 160-164, ELM",,,,,,,,,,,,,
218,218,161,I,,,,,,,,,,,,"Pex14 ligand motif (LIG_Pex14_2), 160-164, ELM",,,,,,,,,,,,,
219,219,162,K,E,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 162-166, ELM|Pex14 ligand motif (LIG_Pex14_2), 160-164, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
220,220,163,A,T,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 162-166, ELM|Pex14 ligand motif (LIG_Pex14_2), 160-164, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14020516-14020516, hg38,16:13926659-13926659","hg19,16:g.14020516G>A, hg38,16:g.13926659G>A",0.833,lung,"carcinoma, adenocarcinoma",,,,
221,221,164,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 162-166, ELM|Pex14 ligand motif (LIG_Pex14_2), 160-164, ELM",,,,,,,,,,,,,
222,222,165,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 162-166, ELM",,,,,,,,,,,,,
223,223,166,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 162-166, ELM",,,,,,,,,,,,,
224,224,167,N,D,,,,,,,,,,,,,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13926671-13926671","hg38,16:g.13926671A>G",0.154,"adrenal_gland, adrenal_gland","adrenal_cortical_carcinoma, functioning",,,,
225,225,168,A,D,,,,,,,,,,,,,cBioPortal,"glioma_mskcc_2019, ucec_tcga_pan_can_atlas_2018","Diffuse Glioma, Endometrial Carcinoma","hg19,16:14020532-14020532","hg19,16:g.14020532C>A",0.496,,,,,,
226,226,168,A,G,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
227,227,168,A,V,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv","blca_bcan_hcrn_2022, msk_met_2021, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14020532-14020532","hg19,16:g.14020532C>T",0.262,,,0.0002107707847831,0.0007960262370248,,
228,228,169,V,,,,,,,,,,,,,,,,,,,,,,,,,
229,229,170,A,S,,,,,,,,,,,,,COSMIC,,,"hg38,16:13926680-13926680","hg38,16:g.13926680G>T",0.025,liver,"other, neoplasm",,,,
230,230,171,F,,,,,,,,,,,,"Pex14 ligand motif (LIG_Pex14_2), 171-175, ELM",,,,,,,,,,,,,
231,231,172,D,H,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Pex14 ligand motif (LIG_Pex14_2), 171-175, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
232,232,172,D,N,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Pex14 ligand motif (LIG_Pex14_2), 171-175, ELM",,cBioPortal,"msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14020543-14020543","hg19,16:g.14020543G>A",0.098,,,,,,
233,233,173,T,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM|Pex14 ligand motif (LIG_Pex14_2), 171-175, ELM",,,,,,,,,,,,,
234,234,174,G,R,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM|Pex14 ligand motif (LIG_Pex14_2), 171-175, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
235,235,175,F,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM|Pex14 ligand motif (LIG_Pex14_2), 171-175, ELM",,COSMIC,,,"hg38,16:13926695-13926695","hg38,16:g.13926695T>G",0.608,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,,,
236,236,176,C,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,,,,,,,,,,,,
237,237,177,H,L,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,COSMIC,,,"hg38,16:13926702-13926702","hg38,16:g.13926702A>T",0.252,prostate,carcinoma,,,,
238,238,177,H,R,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14020559-14020559","hg19,16:g.14020559A>G",0.153,,,,,,
239,239,177,H,Y,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
240,240,178,V,L,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
241,241,178,V,M,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
242,242,179,E,K,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14020564-14020564","hg19,16:g.14020564G>A",0.737,,,,,,
243,243,180,R,K,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14020568-14020568, hg38,16:13926711-13926711","hg19,16:g.14020568G>A, hg38,16:g.13926711G>A",0.259,skin,"carcinoma, squamous_cell_carcinoma",,,,
244,244,180,R,T,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14020568-14020568","hg19,16:g.14020568G>C",0.590,,,,,,
245,245,181,V,M,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
246,246,182,M,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 172-182, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 173-182, ELM",,,,,,,,,,,,,
247,247,183,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 183-187, ELM",,,,,,,,,,,,,
248,248,184,N,D,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 183-187, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
249,249,185,L,F,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 183-187, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14020582-14020582, hg38,16:13926725-13926725","hg19,16:g.14020582C>T, hg38,16:g.13926725C>T",0.781,", lung","carcinoma, adenocarcinoma, malignant_melanoma",,,,
250,250,185,L,I,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 183-187, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14020582-14020582","hg19,16:g.14020582C>A",0.496,,,3.9770286823e-06,,,
251,251,185,L,P,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 183-187, ELM",,COSMIC,,,"hg38,16:13926726-13926726","hg38,16:g.13926726T>C",0.887,"skin, trunk","malignant_melanoma, nodular",,,,
252,252,185,L,R,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 183-187, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14020583-14020583","hg19,16:g.14020583T>G",0.888,,,,,,
253,253,186,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 183-187, ELM",,,,,,,,,,,,,
254,254,187,V,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 187-189, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 183-187, ELM",,,,,,,,,,,,,
255,255,188,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 187-189, ELM",,,,,,,,,,,,,
256,256,189,K,R,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 187-189, ELM",,COSMIC,,,"hg38,16:13926738-13926738","hg38,16:g.13926738A>G",0.282,"large_intestine, colon, descending","carcinoma, adenocarcinoma",,,,
257,257,190,L,,,,,,,,,,,,,,,,,,,,,,,,,
258,258,191,Y,C,P,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 191-194, ELM",,COSMIC,,,"hg38,16:13926744-13926744","hg38,16:g.13926744A>G",0.544,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,
259,259,192,L,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 191-194, ELM",,,,,,,,,,,,,
260,260,193,W,C,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 193-197, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 191-194, ELM",,COSMIC,,,"hg38,16:13926751-13926751","hg38,16:g.13926751G>T",0.894,breast,"carcinoma, ductal_carcinoma",,,,
261,261,193,W,R,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 193-197, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 191-194, ELM",,cBioPortal,ucec_ccr_msk_2022,Endometrial Carcinoma,"hg19,16:14020606-14020606","hg19,16:g.14020606T>C",0.849,,,,,,
262,262,194,P,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 193-197, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 191-194, ELM",,,,,,,,,,,,,
263,263,195,R,,,,,,,,,,,,"SPAK-OSR1 docking motif (DOC_SPAK_OSR1_1), 195-199, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 193-197, ELM",,,,,,,,,,,,,
264,264,196,F,L,,,,,,,,,,,"SPAK-OSR1 docking motif (DOC_SPAK_OSR1_1), 195-199, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 193-197, ELM",,"cBioPortal,COSMIC",lusc_tcga_pan_can_atlas_2018,Lung Squamous Cell Carcinoma,"hg19,16:14021888-14021888, hg38,16:13928031-13928031","hg19,16:g.14021888C>A, hg38,16:g.13928031C>A",0.820,lung,"carcinoma, squamous_cell_carcinoma",,,,
265,265,197,H,,,,,,,,,,,,"SPAK-OSR1 docking motif (DOC_SPAK_OSR1_1), 195-199, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 193-197, ELM",,,,,,,,,,,,,
266,266,198,V,L,,,,,,,,,,,"SPAK-OSR1 docking motif (DOC_SPAK_OSR1_1), 195-199, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14021892-14021892, hg38,16:13928035-13928035","hg19,16:g.14021892G>T, hg38,16:g.13928035G>T",0.046,endometrium,"carcinoma, mixed_serous_and_endometrioid_carcinoma",,,,
267,267,199,A,,,,,,,,,,,,"SPAK-OSR1 docking motif (DOC_SPAK_OSR1_1), 195-199, ELM|USP7 binding motif (DOC_USP7_MATH_1), 199-203, ELM",,,,,,,,,,,,,
268,268,200,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 199-203, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 200-205, ELM",,,,,,,,,,,,,
269,269,201,N,H,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 199-203, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 200-205, ELM",,cBioPortal,rectal_msk_2022,Bowel,"hg19,16:14021901-14021901","hg19,16:g.14021901A>C",0.153,,,,,,
270,270,202,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 199-203, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 200-205, ELM",,,,,,,,,,,,,
271,271,203,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 199-203, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 200-205, ELM",,,,,,,,,,,,,
272,272,204,L,V,,,,,,,,,,,"WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 200-205, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14021910-14021910","hg19,16:g.14021910T>G",0.659,,,,,,
273,273,205,E,K,,,,,,,,,,,"WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 200-205, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14021913-14021913, hg38,16:13928056-13928056","hg19,16:g.14021913G>A, hg38,16:g.13928056G>A",0.209,lung,"carcinoma, adenocarcinoma",,,,
274,274,206,Q,,,,,,,,,,,,,,,,,,,,,,,,,
275,275,207,H,,,,,,,,,,,,,,,,,,,,,,,,,
276,276,208,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,,,,,,,,,,,,
277,277,209,P,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14021925-14021925","hg19,16:g.14021925C>A",0.552,,,,,,
278,278,210,E,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, lung_msk_pdx","Bladder Urothelial Carcinoma, Lung","hg19,16:14021928-14021928, hg38,16:13928071-13928071","hg19,16:g.14021928G>A, hg38,16:g.13928071G>A",0.267,"urinary_tract, bladder",carcinoma,,,,
279,279,210,E,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14021929-14021929, hg38,16:13928072-13928072","hg19,16:g.14021929A>T, hg38,16:g.13928072A>T",0.413,lung,"carcinoma, adenocarcinoma",,,,
280,280,211,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,,,,,,,,,,,,
281,281,212,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,,,,,,,,,,,,
282,282,213,E,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,cBioPortal,"msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14021937-14021937","hg19,16:g.14021937G>A",0.917,,,,,,
283,283,214,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,,,,,,,,,,,,
284,284,215,H,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM",,,,,,,,,,,,,
285,285,216,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 208-216, ELM|WW domain ligands (DOC_WW_Pin1_4), 216-221, ELM",,,,,,,,,,,,,
286,286,217,S,C,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 216-221, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14021950-14021950, hg38,16:13928093-13928093","hg19,16:g.14021950C>G, hg38,16:g.13928093C>G",0.236,lung,"carcinoma, adenocarcinoma",,,,
287,287,217,S,F,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 216-221, ELM",,"cBioPortal,COSMIC","blca_nmibc_2017, lung_msk_pdx, msk_impact_2017, msk_met_2021, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Lung, Mixed Cancer Types","hg19,16:14021950-14021950, hg38,16:13928093-13928093","hg19,16:g.14021950C>T, hg38,16:g.13928093C>T",0.232,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,
288,288,218,M,I,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 216-221, ELM",,COSMIC,,,"hg38,16:13928097-13928097","hg38,16:g.13928097G>A",0.133,thyroid,carcinoma,,,,
289,289,219,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 216-221, ELM",,,,,,,,,,,,,
290,290,220,P,H,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 216-221, ELM",,cBioPortal,"msk_met_2021, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14021959-14021959","hg19,16:g.14021959C>A",0.307,,,,,,
291,291,221,T,A,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 216-221, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60, msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14021961-14021961, hg38,16:13928104-13928104","hg19,16:g.14021961A>G, hg38,16:g.13928104A>G",0.101,lung,"carcinoma, small_cell_carcinoma",,,,
292,292,221,T,I,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 216-221, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14021962-14021962","hg19,16:g.14021962C>T",0.069,,,,,,
293,293,222,M,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,,,,,,,,,,,,
294,294,223,L,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,,,,,,,,,,,,
295,295,224,A,S,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,COSMIC,,,"hg38,16:13928113-13928113","hg38,16:g.13928113G>T",0.113,liver,"other, neoplasm",,,,
296,296,224,A,V,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
297,297,225,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,,,,,,,,,,,,
298,298,226,Q,H,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:14021978-14021978, hg38,16:13928121-13928121","hg19,16:g.14021978G>C, hg38,16:g.13928121G>C",0.661,lung,"carcinoma, adenocarcinoma",,,,
299,299,227,T,I,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 221-227, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:14021980-14021980, hg38,16:13928123-13928123","hg19,16:g.14021980C>T, hg38,16:g.13928123C>T",0.233,"large_intestine, caecum","carcinoma, adenocarcinoma",,,,
300,300,228,A,T,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM",,"cBioPortal,COSMIC",hcc_inserm_fr_2015,Hepatocellular Carcinoma,"hg19,16:14021982-14021982, hg38,16:13928125-13928125","hg19,16:g.14021982G>A, hg38,16:g.13928125G>A",0.197,liver,"carcinoma, hepatocellular_carcinoma",,,,
301,301,228,A,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM",,COSMIC,,,"hg38,16:13928126-13928126","hg38,16:g.13928126C>T",0.322,prostate,carcinoma,7.9574752523e-06,,,
302,302,229,I,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14021985-14021985, hg38,16:13928128-13928128","hg19,16:g.14021985A>G, hg38,16:g.13928128A>G",0.112,lung,"carcinoma, large_cell_neuroendocrine_carcinoma",,,,
303,303,230,L,P,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
304,304,231,D,G,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14021992-14021992, hg38,16:13928135-13928135","hg19,16:g.14021992A>G, hg38,16:g.13928135A>G",0.664,large_intestine,"carcinoma, adenocarcinoma",,,,
305,305,231,D,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 225-231, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:14021992-14021992","hg19,16:g.14021992A>T",0.744,,,,,,
306,306,232,I,F,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,"cBioPortal,COSMIC",blca_bgi,Bladder Urothelial Carcinoma,"hg19,16:14021994-14021994, hg38,16:13928137-13928137","hg19,16:g.14021994A>T, hg38,16:g.13928137A>T",0.682,"urinary_tract, bladder","carcinoma, carcinoma, transitional_cell_carcinoma",3.9787376261e-06,,,
307,307,233,L,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,,,,,,,,,,,,
308,308,234,N,H,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv","ihch_msk_2021, ihch_mskcc_2020",Intrahepatic Cholangiocarcinoma,"hg19,16:14022000-14022000","hg19,16:g.14022000A>C",0.182,,,1.98954296219e-05,3.18369945877e-05,,
309,309,234,N,K,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14022002-14022002, hg38,16:13928145-13928145","hg19,16:g.14022002T>G, hg38,16:g.13928145T>G",0.160,endometrium,"carcinoma, endometrioid_carcinoma",,,,
310,310,235,A,T,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
311,311,235,A,V,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,cBioPortal,"ccle_broad_2019, msk_met_2021",Mixed Cancer Types,"hg19,16:14022004-14022004","hg19,16:g.14022004C>T",0.210,,,,,,
312,312,236,C,R,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
313,313,237,L,P,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,16:14022010-14022010, hg38,16:13928153-13928153","hg19,16:g.14022010T>C, hg38,16:g.13928153T>C",0.811,lung,"carcinoma, squamous_cell_carcinoma",,,,
314,314,238,K,E,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 238-242, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 229-238, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
315,315,239,E,K,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 238-242, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",cfdna_msk_2019,Mixed Cancer Types,"hg19,16:14022015-14022015","hg19,16:g.14022015G>A",0.724,,,,,,
316,316,239,E,Q,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 238-242, ELM",,cBioPortal,"msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,16:14022015-14022015","hg19,16:g.14022015G>C",0.375,,,,,,
317,317,240,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 238-242, ELM",,,,,,,,,,,,,
318,318,241,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 238-242, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,,,,,,,,,,,,
319,319,242,C,Y,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 238-242, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,16:14022025-14022025, hg38,16:13928168-13928168","hg19,16:g.14022025G>A, hg38,16:g.13928168G>A",0.079,penis,"carcinoma, squamous_cell_carcinoma",3.9791175909e-06,,,
320,320,243,H,R,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
321,321,244,N,D,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,16:14022030-14022030","hg19,16:g.14022030A>G",0.504,,,,,,
322,322,244,N,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
323,323,245,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,,,,,,,,,,,,
324,324,246,S,L,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","coadread_mskresistance_2022, msk_met_2021, rectal_msk_2022, skcm_broad_brafresist_2012, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Bowel, Colorectal Adenocarcinoma, Cutaneous Melanoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14022037-14022037, hg38,16:13928180-13928180","hg19,16:g.14022037C>T, hg38,16:g.13928180C>T",0.090,", endometrium, large_intestine, rectum","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, malignant_melanoma",3.9799410969e-06,,,
325,325,246,S,P,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,cBioPortal,rectal_msk_2019,Colorectal Adenocarcinoma,"hg19,16:14022036-14022036","hg19,16:g.14022036T>C",0.197,,,,,,
326,326,246,S,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
327,327,247,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,,,,,,,,,,,,
328,328,248,E,Q,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14022042-14022042","hg19,16:g.14022042G>C",0.284,,,,,,
329,329,249,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 241-249, ELM",,,,,,,,,,,,,
330,330,250,E,K,,,,,,,,,,,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14022048-14022048","hg19,16:g.14022048G>A",0.499,,,,,,
331,331,251,D,N,,,,,,,,,,,,,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13928194-13928194","hg38,16:g.13928194G>A",0.375,lung,"carcinoma, adenocarcinoma",,,,
332,332,251,D,V,,,,,,,,,,,,,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,16:14022052-14022052","hg19,16:g.14022052A>T",0.723,,,,,,
333,333,252,L,V,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14022054-14022054","hg19,16:g.14022054T>G",0.117,,,,,,
334,334,253,S,A,,,,,,,,,,,,,Manual annotations from ERCC4_icope_sentieon_input.csv,,,,,,,,,,,
335,335,253,S,F,,,,,,,,,,,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, glioma_msk_2018, pancan_pcawg_2020","Colorectal Adenocarcinoma, Diffuse Glioma, Mixed Cancer Types","hg19,16:14022058-14022058, hg38,16:13928201-13928201","hg19,16:g.14022058C>T, hg38,16:g.13928201C>T",0.414,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,,,
336,336,254,L,,,,,,,,,,,,,,,,,,,,,,,,,
337,337,255,E,,,,,,,,,,,,,,,,,,,,,,,,,
338,338,256,N,,,,,,,,,,,,,,,,,,,,,,,,,
339,339,257,A,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
340,340,257,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:14022070-14022070, hg38,16:13928213-13928213","hg19,16:g.14022070C>T, hg38,16:g.13928213C>T",0.172,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
341,341,258,I,,,,,,,,,,,,,,,,,,,,,,,,,
342,342,259,G,E,,,,,,,,,,,,,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13928219-13928219","hg38,16:g.13928219G>A",0.277,prostate,carcinoma,9.95762036772e-05,,,
343,343,260,K,,,,Ubq,,,Ac,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 260-264, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,,,,,,,,,,,,
344,344,261,P,L,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 260-264, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
345,345,262,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 260-264, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,,,,,,,,,,,,
346,346,263,D,H,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 260-264, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14022087-14022087","hg19,16:g.14022087G>C",0.187,,,,,,
347,347,263,D,N,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 260-264, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,cBioPortal,lung_msk_pdx,Lung,"hg19,16:14022087-14022087","hg19,16:g.14022087G>A",0.285,,,,,,
348,348,264,K,E,,,Ubq,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 260-264, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
349,349,264,K,N,,,Ubq,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 260-264, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,cBioPortal,"paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,16:14022092-14022092","hg19,16:g.14022092G>T",0.311,,,,,,
350,350,265,T,I,,,,,,,,,,,"SH3 ligand (LIG_SH3_4), 260-267, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
351,351,266,I,M,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
352,352,266,I,V,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14024570-14024570, hg38,16:13930713-13930713","hg19,16:g.14024570A>G, hg38,16:g.13930713A>G",0.119,"large_intestine, colon, descending","carcinoma, adenocarcinoma",,,,
353,353,267,R,C,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,"cBioPortal,COSMIC,Manual annotations from ERCC4_icope_sentieon_input.csv,Manual annotations from mutations_clinvar.csv","brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, coadread_tcga_pan_can_atlas_2018, mel_dfci_2019, msk_impact_2017, msk_met_2021, pancan_pcawg_2020, rectal_msk_2019, ucec_msk_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Invasive Breast Carcinoma, Melanoma, Mixed Cancer Types","hg19,16:14024573-14024573, hg38,16:13930716-13930716","hg19,16:g.14024573C>T, hg38,16:g.13930716C>T",0.470,"breast, endometrium, pancreas","carcinoma, carcinoma, ductal_carcinoma, carcinoma, endometrioid_carcinoma",3.184459836e-05,,,
354,354,267,R,G,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,cBioPortal,bowel_colitis_msk_2022,Bowel,"hg19,16:14024573-14024573","hg19,16:g.14024573C>G",0.553,,,,,,
355,355,267,R,H,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
356,356,267,R,L,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|SH3 ligand (LIG_SH3_4), 260-267, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv","esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,16:14024574-14024574","hg19,16:g.14024574G>T",0.603,,,2.38826882354e-05,,,
357,357,268,H,R,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM",,COSMIC,,,"hg38,16:13930720-13930720","hg38,16:g.13930720A>G",0.302,ovary,"carcinoma, clear_cell_carcinoma",,,,
358,358,269,Y,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 269-272, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 269-272, ELM",,,,,,,,,,,,,
359,359,270,L,P,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 269-272, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 269-272, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
360,360,271,D,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 269-272, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 269-272, ELM",,,,,,,,,,,,,
361,361,272,P,H,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 269-272, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 269-272, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14024589-14024589","hg19,16:g.14024589C>A",0.638,,,,,,
362,362,272,P,S,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 269-272, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 269-272, ELM",,COSMIC,,,"hg38,16:13930731-13930731","hg38,16:g.13930731C>T",0.447,skin,malignant_melanoma,,,,
363,363,273,L,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM",,,,,,,,,,,,,
364,364,274,W,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 266-274, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM",,,,,,,,,,,,,
365,365,275,H,Y,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
366,366,276,Q,H,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14024602-14024602, hg38,16:13930745-13930745","hg19,16:g.14024602G>C, hg19,16:g.14024602G>T, hg38,16:g.13930745G>C","0.394, 0.395",lung,"carcinoma, squamous_cell_carcinoma",,,,
367,367,277,L,P,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
368,368,278,G,A,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,16:14024607-14024607, hg38,16:13930750-13930750","hg19,16:g.14024607G>C, hg38,16:g.13930750G>C",0.308,lung,"carcinoma, non_small_cell_carcinoma",,,,
369,369,279,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 279-285, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 271-279, ELM",,,,,,,,,,,,,
370,370,280,K,M,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 279-285, ELM",,Manual annotations from ERCC4_icope_sentieon_input.csv,,,,,,,,,,,
371,371,281,T,I,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 279-285, ELM",,COSMIC,,,"hg38,16:13930759-13930759","hg38,16:g.13930759C>T",0.664,"central_nervous_system, occipital_lobe","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
372,372,282,K,,,,Ubq,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 279-285, ELM",,,,,,,,,,,,,
373,373,283,S,F,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 279-285, ELM",,"cBioPortal,COSMIC",cscc_dfarber_2015,Cutaneous Squamous Cell Carcinoma,"hg19,16:14024622-14024622, hg38,16:13930765-13930765","hg19,16:g.14024622C>T, hg38,16:g.13930765C>T",0.284,skin,"carcinoma, squamous_cell_carcinoma",,,,
374,374,283,S,T,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 279-285, ELM",,"cBioPortal,COSMIC","gbm_tcga, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, lgggbm_tcga_pub, pancan_pcawg_2020","Diffuse Glioma, Glioblastoma Multiforme, Mixed Cancer Types","hg19,16:14024621-14024621, hg38,16:13930764-13930764","hg19,16:g.14024621T>A, hg38,16:g.13930764T>A",0.073,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
375,375,284,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 279-285, ELM",,,,,,,,,,,,,
376,376,285,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 279-285, ELM",,,,,,,,,,,,,
377,377,286,Q,K,,,,,,,,,,,,,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,16:14024630-14024630","hg19,16:g.14024630C>A",0.174,,,,,,
378,378,287,D,N,,,,,,,,,,,,,cBioPortal,"hnsc_tcga, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,16:14024633-14024633","hg19,16:g.14024633G>A",0.548,,,,,,
379,379,288,L,,,,,,,,,,,,,,,,,,,,,,,,,
380,380,289,K,,,,,,,Ac,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM",,,,,,,,,,,,,
381,381,290,I,M,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Nuclear receptor box (LIG_NRBOX), 290-296, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
382,382,291,L,V,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Nuclear receptor box (LIG_NRBOX), 290-296, ELM",,cBioPortal,ucec_ccr_msk_2022,Endometrial Carcinoma,"hg19,16:14024645-14024645","hg19,16:g.14024645T>G",0.608,,,,,,
383,383,292,R,Q,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 292-296, ELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Nuclear receptor box (LIG_NRBOX), 290-296, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","mel_mskimpact_2020, metastatic_solid_tumors_mich_2017, msk_impact_2017, msk_met_2021, ucec_tcga_pan_can_atlas_2018","Cutaneous Melanoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14024649-14024649, hg38,16:13930792-13930792","hg19,16:g.14024649G>A, hg38,16:g.13930792G>A",0.728,skin,malignant_melanoma,2.38857306645e-05,6.37145587767e-05,,
384,384,293,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 292-296, ELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Nuclear receptor box (LIG_NRBOX), 290-296, ELM",,,,,,,,,,,,,
385,385,294,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 292-296, ELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Nuclear receptor box (LIG_NRBOX), 290-296, ELM",,,,,,,,,,,,,
386,386,295,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 292-296, ELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Nuclear receptor box (LIG_NRBOX), 290-296, ELM",,,,,,,,,,,,,
387,387,296,Q,L,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 292-296, ELM|APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Nuclear receptor box (LIG_NRBOX), 290-296, ELM",,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,16:14024661-14024661","hg19,16:g.14024661A>T",0.086,,,,,,
388,388,297,Y,C,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 297-300, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 297-300, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
389,389,297,Y,H,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 297-300, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 297-300, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
390,390,297,Y,N,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 297-300, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 297-300, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
391,391,298,L,F,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 297-300, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 297-300, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14024666-14024666","hg19,16:g.14024666C>T",0.440,,,,,,
392,392,298,L,I,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 297-300, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 297-300, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, utuc_msk_2019, utuc_pdx_msk_2019","Mixed Cancer Types, Upper Tract Urothelial Carcinoma","hg19,16:14024666-14024666, hg38,16:13930809-13930809","hg19,16:g.14024666C>A, hg38,16:g.13930809C>A",0.400,"urinary_tract, upper_urinary_tract","carcinoma, transitional_cell_carcinoma",,,,
393,393,299,S,F,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 291-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 289-299, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 297-300, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 297-300, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,16:14024670-14024670","hg19,16:g.14024670C>T",0.091,,,,,,
394,394,300,Q,H,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 297-300, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 297-300, ELM",,"cBioPortal,COSMIC","gct_msk_2016, msk_impact_2017, msk_met_2021","Mixed Cancer Types, Testis","hg19,16:14024674-14024674, hg38,16:13930817-13930817","hg19,16:g.14024674G>C, hg38,16:g.13930817G>C",0.478,testis,"germ_cell_tumour, mixed",,,,
395,395,301,Y,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 301-304, ELM",,,,,,,,,,,,,
396,396,302,D,E,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 301-304, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:14024680-14024680","hg19,16:g.14024680T>G",0.536,,,,,,
397,397,302,D,G,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 301-304, ELM",,COSMIC,,,"hg38,16:13930822-13930822","hg38,16:g.13930822A>G",0.767,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,
398,398,302,D,H,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 301-304, ELM",,cBioPortal,paired_bladder_2022,Bladder/Urinary Tract,"hg19,16:14024678-14024678","hg19,16:g.14024678G>C",0.755,,,,,,
399,399,303,C,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 301-304, ELM",,,,,,,,,,,,,
400,400,304,V,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 301-304, ELM",,,,,,,,,,,,,
401,401,305,T,A,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM",,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14024687-14024687","hg19,16:g.14024687A>G",0.586,,,7.9584251868e-06,,,
402,402,305,T,I,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM",,COSMIC,,,"hg38,16:13930831-13930831","hg38,16:g.13930831C>T",0.660,"large_intestine, ovary","carcinoma, adenocarcinoma, carcinoma, serous_carcinoma",,,,
403,403,305,T,S,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 301-305, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_NCK_1), 301-305, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
404,404,306,F,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM",,,,,,,,,,,,,
405,405,307,L,I,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14024693-14024693","hg19,16:g.14024693C>A",0.232,,,,,,
406,406,308,N,K,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
407,407,309,L,I,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 299-309, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14024699-14024699, hg38,16:13930842-13930842","hg19,16:g.14024699C>A, hg38,16:g.13930842C>A",0.236,endometrium,"carcinoma, endometrioid_carcinoma",,3.18552497452e-05,,
408,408,310,L,,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,,,,,,,,,,,,
409,409,311,E,Q,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,cBioPortal,"msk_met_2021, nsclc_ctdx_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14024705-14024705","hg19,16:g.14024705G>C",0.131,,,,,,
410,410,312,S,A,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,Manual annotations from ERCC4_icope_sentieon_input.csv,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14024708-14024708","hg19,16:g.14024708T>G",0.143,,,2.78564833975e-05,6.368615463e-05,,
411,411,312,S,C,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
412,412,312,S,F,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14024709-14024709, hg38,16:13930852-13930852","hg19,16:g.14024709C>T, hg38,16:g.13930852C>T",0.641,endometrium,"carcinoma, endometrioid_carcinoma",,,,
413,413,312,S,Y,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14024709-14024709, hg38,16:13930852-13930852","hg19,16:g.14024709C>A, hg38,16:g.13930852C>A",0.606,"endometrium, large_intestine, colon, ascending","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,,,
414,414,313,L,P,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
415,415,313,L,V,,,,,,,,,,,"Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 305-313, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
416,416,314,R,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM|Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,,,,,,,,,,,,
417,417,315,A,S,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM|Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,COSMIC","msk_impact_2017, tmb_mskcc_2018",Mixed Cancer Types,"hg19,16:14024717-14024717, hg38,16:13930860-13930860","hg19,16:g.14024717G>T, hg38,16:g.13930860G>T",0.038,,"carcinoma, of_unknown_primary",3.9800361387e-06,,,
418,418,315,A,V,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM|Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,COSMIC","coadread_genentech, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14024718-14024718, hg38,16:13930861-13930861","hg19,16:g.14024718C>T, hg38,16:g.13930861C>T",0.081,"large_intestine, colon, skin, trunk","carcinoma, adenocarcinoma, malignant_melanoma",,,,
419,419,316,T,M,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM|Actin-binding motifs (LIG_Actin_WH2_2), 300-316, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","breast_msk_2018, ccle_broad_2019, cfdna_msk_2019, msk_impact_2017, msk_met_2021, prad_msk_stopsack_2021","Breast, Mixed Cancer Types, Prostate Adenocarcinoma","hg19,16:14024721-14024721, hg38,16:13930864-13930864","hg19,16:g.14024721C>T, hg38,16:g.13930864C>T",0.091,"biliary_tract, bile_duct, breast, prostate","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",1.19411539931e-05,,,
420,420,317,E,G,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",pptc_2019,Mixed Cancer Types,"hg19,16:14024724-14024724","hg19,16:g.14024724A>G",0.264,,,3.9806381759e-06,,,
421,421,317,E,K,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,16:14024723-14024723, hg38,16:13930866-13930866","hg19,16:g.14024723G>A, hg38,16:g.13930866G>A",0.194,skin,"carcinoma, basal_cell_carcinoma",,,,
422,422,318,K,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 309-318, ELM",,,,,,,,,,,,,
423,423,319,A,D,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM",,cBioPortal,lung_msk_mind_2020,Lung,"hg19,16:14024730-14024730","hg19,16:g.14024730C>A",0.152,,,,,,
424,424,319,A,V,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM",,cBioPortal,coadread_mskresistance_2022,Colorectal Adenocarcinoma,"hg19,16:14024722-14024731","hg19,16:g.14024722_14024731delinsAGAGAAGGTG",,,,,,,
425,425,320,F,V,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 314-320, ELM",,cBioPortal,ucec_ccr_msk_2022,Endometrial Carcinoma,"hg19,16:14024732-14024732","hg19,16:g.14024732T>G",0.113,,,,,,
426,426,321,G,R,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
427,427,322,Q,H,,,,,,,,,,,,,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14024740-14024740, hg38,16:13930883-13930883","hg19,16:g.14024740G>C, hg38,16:g.13930883G>C",0.036,lung,"carcinoma, adenocarcinoma",,,,
428,428,323,N,,,,,,,,,,,,,,,,,,,,,,,,,
429,429,324,S,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,,,,,,,,,,,,
430,430,325,G,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,,,,,,,,,,,,
431,431,326,W,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,,,,,,,,,,,,
432,432,327,L,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,,,,,,,,,,,,
433,433,328,F,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,,,,,,,,,,,,
434,434,329,L,F,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
435,435,329,L,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14026025-14026025","hg19,16:g.14026025C>G",0.406,,,,,,
436,436,330,D,A,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
437,437,330,D,H,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 324-330, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
438,438,331,S,C,,,,,,,,,,,,,cBioPortal,blca_bcan_hcrn_2022,Bladder Urothelial Carcinoma,"hg19,16:14026032-14026032","hg19,16:g.14026032C>G",0.372,,,,,,
439,439,331,S,T,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",acc_2019,Adenoid Cystic Carcinoma,"hg19,16:14026031-14026031","hg19,16:g.14026031T>A",0.130,,,5.57213930348e-05,3.1843077315e-05,,
440,440,332,S,,,,,,,,,,,,,,,,,,,,,,,,,
441,441,333,T,,,,,,,,,,,,,,,,,,,,,,,,,
442,442,334,S,L,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","coadread_dfci_2016, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,16:14026041-14026041, hg38,16:13932184-13932184","hg19,16:g.14026041C>T, hg38,16:g.13932184C>T",0.243,large_intestine,"carcinoma, adenocarcinoma",0.0001552795031056,0.0001274859765426,,
443,443,335,M,T,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
444,444,335,M,V,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14026043-14026043","hg19,16:g.14026043A>G",0.362,,,3.9814940158e-06,3.1841049481e-05,,
445,445,336,F,,,,,,,,,,,,,,,,,,,,,,,,,
446,446,337,I,V,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
447,447,338,N,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
448,448,339,A,G,,,,,,,,,,,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14026056-14026056","hg19,16:g.14026056C>G",0.498,,,,,,
449,449,340,R,Q,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 340-343, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","cesc_tcga, cesc_tcga_pan_can_atlas_2018, crc_msk_2017, msk_impact_2017, msk_met_2021","Cervical Squamous Cell Carcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14026059-14026059, hg38,16:13932202-13932202","hg19,16:g.14026059G>A, hg38,16:g.13932202G>A",0.497,"cervix, large_intestine","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",1.99309591575e-05,,,
450,450,341,A,S,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 340-343, ELM",,"cBioPortal,COSMIC","breast_msk_2018, msk_met_2021","Breast, Mixed Cancer Types","hg19,16:14026061-14026061, hg38,16:13932204-13932204","hg19,16:g.14026061G>T, hg38,16:g.13932204G>T",0.095,breast,"carcinoma, ductal_carcinoma",,,,
451,451,342,R,M,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 340-343, ELM",,cBioPortal,"lung_msk_pdx, msk_met_2021","Lung, Mixed Cancer Types","hg19,16:14026065-14026065","hg19,16:g.14026065G>T",0.793,,,,,,
452,452,343,V,I,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 340-343, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
453,453,344,Y,C,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
454,454,344,Y,F,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
455,455,345,H,Y,,,,,,,,,,,,,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,16:14026073-14026073","hg19,16:g.14026073C>T",0.097,,,,,,
456,456,346,L,,,,,,,,,,,,,,,,,,,,,,,,,
457,457,347,P,S,,,,,,,,,,,,,cBioPortal,rectal_msk_2019,Colorectal Adenocarcinoma,"hg19,16:14026079-14026079","hg19,16:g.14026079C>T",0.095,,,,,,
458,458,348,D,,,,,,,,,,,,,,,,,,,,,,,,,
459,459,349,A,S,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 349-353, ELM",,COSMIC,,,"hg38,16:13932228-13932228","hg38,16:g.13932228G>T",0.040,liver,"other, neoplasm",,,,
460,460,349,A,T,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 349-353, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,16:14026085-14026085","hg19,16:g.14026085G>A",0.064,,,3.9995520502e-06,,,
461,461,350,K,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 349-353, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 350-354, ELM",,,,,,,,,,,,,
462,462,351,M,I,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 349-353, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 350-354, ELM",,cBioPortal,luad_cptac_2020,Lung Adenocarcinoma,"hg19,16:14026093-14026093","hg19,16:g.14026093G>A",0.064,,,,,,
463,463,352,S,R,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 349-353, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 350-354, ELM",,COSMIC,,,"hg38,16:13932239-13932239","hg38,16:g.13932239T>A",0.024,breast,"carcinoma, ductal_carcinoma",,,,
464,464,353,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|USP7 binding motif (DOC_USP7_MATH_1), 349-353, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 350-354, ELM",,,,,,,,,,,,,
465,465,354,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 350-354, ELM",,,,,,,,,,,,,
466,466,355,E,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM",,cBioPortal,"msk_met_2021, nsclc_ctdx_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14026103-14026103","hg19,16:g.14026103G>A",0.076,,,,,,
467,467,356,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 356-360, ELM",,,,,,,,,,,,,
468,468,357,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 356-360, ELM",,,,,,,,,,,,,
469,469,358,S,P,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 356-360, ELM",,cBioPortal,cll_broad_2015,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,"hg19,16:14026112-14026112","hg19,16:g.14026112T>C",0.028,,,,,,
470,470,359,E,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 356-360, ELM",,COSMIC,,,"hg38,16:13932258-13932258","hg38,16:g.13932258G>A",0.120,breast,carcinoma,,,,
471,471,359,E,Q,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 356-360, ELM",,"cBioPortal,COSMIC",blca_bgi,Bladder Urothelial Carcinoma,"hg19,16:14026115-14026115, hg38,16:13932258-13932258","hg19,16:g.14026115G>C, hg38,16:g.13932258G>C",0.124,"urinary_tract, bladder","carcinoma, carcinoma, transitional_cell_carcinoma",,,,
472,472,360,K,R,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 356-360, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 360-364, ELM",,"cBioPortal,COSMIC","cll_broad_2015, lcll_broad_2013",Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,"hg19,16:14026119-14026119, hg38,16:13932262-13932262","hg19,16:g.14026119A>G, hg38,16:g.13932262A>G",0.139,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,,,
473,473,361,M,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 360-364, ELM",,,,,,,,,,,,,
474,474,362,E,G,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 360-364, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:14026125-14026125, hg38,16:13932268-13932268","hg19,16:g.14026125A>G, hg38,16:g.13932268A>G",0.046,stomach,"carcinoma, adenocarcinoma",,,,
475,475,363,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 353-363, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 354-363, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 360-364, ELM",,,,,,,,,,,,,
476,476,364,K,E,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 360-364, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
477,477,365,E,Q,,,,,,,,,,,,,COSMIC,,,"hg38,16:13932276-13932276","hg38,16:g.13932276G>C",0.083,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,,,
478,478,366,G,E,,,,,,,,,,,,,COSMIC,,,"hg38,16:13932280-13932280","hg38,16:g.13932280G>A",0.027,large_intestine,"carcinoma, adenocarcinoma",,,,
479,479,366,G,R,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:14026136-14026136","hg19,16:g.14026136G>C",0.103,,,,,,
480,480,366,G,V,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14026137-14026137, hg38,16:13932280-13932280","hg19,16:g.14026137G>T, hg38,16:g.13932280G>T",0.049,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,,,
481,481,367,E,K,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 367-373, ELM",,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,16:14026139-14026139","hg19,16:g.14026139G>A",0.097,,,,,,
482,482,368,E,K,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 367-373, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv","difg_glass_2019, gbm_tcga_pan_can_atlas_2018, pancan_pcawg_2020","Diffuse Glioma, Glioblastoma Multiforme, Mixed Cancer Types","hg19,16:14026142-14026142","hg19,16:g.14026142G>A",0.146,,,6.43376439555e-05,0.0001910949742022,,
483,483,369,T,A,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 367-373, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14028051-14028051, hg38,16:13934194-13934194","hg19,16:g.14028051A>G, hg38,16:g.13934194A>G",0.049,endometrium,"carcinoma, endometrioid_carcinoma",,,,
484,484,370,K,N,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 367-373, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
485,485,371,K,R,,,Ubq,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 367-373, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
486,486,372,E,K,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 367-373, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
487,487,373,L,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 367-373, ELM",,,,,,,,,,,,,
488,488,374,V,L,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14028066-14028066","hg19,16:g.14028066G>C",0.190,,,,,,
489,489,375,L,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM",,,,,,,,,,,,,
490,490,376,E,Q,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM",,"cBioPortal,COSMIC","blca_nmibc_2017, msk_impact_2017, msk_met_2021, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14028072-14028072, hg38,16:13934215-13934215","hg19,16:g.14028072G>C, hg38,16:g.13934215G>C",0.486,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,
491,491,377,S,G,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 368-377, ELM",,COSMIC,,,"hg38,16:13934218-13934218","hg38,16:g.13934218A>G",0.072,"soft_tissue, striated_muscle, paratestis","rhabdomyosarcoma, embryonal",,3.18511912346e-05,,
492,492,378,N,,,,,,,,,,,,,,,,,,,,,,,,,
493,493,379,P,S,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from ERCC4_icope_sentieon_input.csv,Manual annotations from mutations_clinvar.csv","mixed_pipseq_2017, thyroid_mskcc_2016","Mixed Cancer Types, Thyroid","hg19,16:14028081-14028081, hg38,16:13934224-13934224","hg19,16:g.14028081C>T, hg38,16:g.13934224C>T",0.526,"endometrium, prostate, thyroid","carcinoma, carcinoma, anaplastic_carcinoma, other, adenosarcoma",0.0039996171851946,0.0048537488823605,,
494,494,380,K,,,,Ubq,,,,,,,,,,,,,,,,,,,,,
495,495,381,W,G,,,,,,,,,,,,,"cBioPortal,COSMIC",brca_tcga,Invasive Breast Carcinoma,"hg19,16:14028087-14028087, hg38,16:13934230-13934230","hg19,16:g.14028087T>G, hg38,16:g.13934230T>G",0.514,breast,carcinoma,,,,
496,496,381,W,L,,,,,,,,,,,,,cBioPortal,prad_tcga_pub,Prostate Adenocarcinoma,"hg19,16:14028088-14028088","hg19,16:g.14028088G>T",0.611,,,,,,
497,497,382,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018",Breast,"hg19,16:14028090-14028090, hg38,16:13934233-13934233","hg19,16:g.14028090G>A, hg38,16:g.13934233G>A",0.197,breast,"carcinoma, ductal_carcinoma",,,,
498,498,383,A,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 383-389, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","msk_impact_2017, thyroid_mskcc_2016","Mixed Cancer Types, Thyroid","hg19,16:14028094-14028094, hg38,16:13934237-13934237","hg19,16:g.14028094C>T, hg38,16:g.13934237C>T",0.167,thyroid,"carcinoma, anaplastic_carcinoma",,,,
499,499,384,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 383-389, ELM",,,,,,,,,,,,,
500,500,385,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 383-389, ELM",,,,,,,,,,,,,
501,501,386,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 383-389, ELM",,,,,,,,,,,,,
502,502,387,V,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 383-389, ELM",,,,,,,,,,,,,
503,503,388,L,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 383-389, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv","msk_met_2021, ucs_jhu_2014","Mixed Cancer Types, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,16:14028108-14028108","hg19,16:g.14028108T>G",0.503,,,,,,
504,504,389,K,,,,Ubq,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 383-389, ELM",,,,,,,,,,,,,
505,505,390,E,,,,,,,,,,,,,,,,,,,,,,,,,
506,506,391,I,,,,,,,,,,,,,,,,,,,,,,,,,
507,507,392,E,Q,,,,,,,,,,,,,COSMIC,,,"hg38,16:13934263-13934263","hg38,16:g.13934263G>C",0.169,lung,"carcinoma, adenocarcinoma",,,,
508,508,393,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14028124-14028124, hg38,16:13934267-13934267","hg19,16:g.14028124C>T, hg38,16:g.13934267C>T",0.045,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
509,509,394,E,,,,,,,,,,,,,,,,,,,,,,,,,
510,510,395,N,,,,,,,,,,,,,,,,,,,,,,,,,
511,511,396,K,,,,,,,,,,,,,,,,,,,,,,,,,
512,512,397,E,G,,,,,,,,,,,,,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,16:14028136-14028136, hg38,16:13934279-13934279","hg19,16:g.14028136A>G, hg38,16:g.13934279A>G",0.040,breast,"carcinoma, ductal_carcinoma",,,,
513,513,397,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017","Breast, Mixed Cancer Types","hg19,16:14028135-14028135, hg38,16:13934278-13934278","hg19,16:g.14028135G>A, hg38,16:g.13934278G>A",0.062,breast,"carcinoma, carcinoma, ER-PR-positive_carcinoma",,,,
514,514,398,S,G,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
515,515,398,S,N,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
516,516,398,S,T,,,,,,,,,,,,,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_access_2021, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14028139-14028139","hg19,16:g.14028139G>C",0.062,,,,,,
517,517,399,E,G,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14028142-14028142, hg38,16:13934285-13934285","hg19,16:g.14028142A>G, hg38,16:g.13934285A>G",0.165,endometrium,"carcinoma, endometrioid_carcinoma",,,,
518,518,400,A,S,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:14028144-14028144, hg38,16:13934287-13934287","hg19,16:g.14028144G>T, hg38,16:g.13934287G>T",0.160,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,,,
519,519,400,A,V,,,,,,,,,,,,,Manual annotations from ERCC4_icope_sentieon_input.csv,,,,,,,,,,,
520,520,401,L,F,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
521,521,402,G,,,,,,,,,,,,,,,,,,,,,,,,,
522,522,403,G,C,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14028153-14028153, hg38,16:13934296-13934296","hg19,16:g.14028153G>T, hg38,16:g.13934296G>T",0.313,lung,"carcinoma, adenocarcinoma",,,,
523,523,403,G,R,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
524,524,404,P,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
525,525,405,G,,,,,,,,,,,,,,,,,,,,,,,,,
526,526,406,Q,R,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",bowel_colitis_msk_2022,Bowel,"hg19,16:14029006-14029006","hg19,16:g.14029006A>G",0.064,,,1.59264833528e-05,,,
527,527,407,V,,,,,,,,,,,,,,,,,,,,,,,,,
528,528,408,L,,,,,,,,,,,,,,,,,,,,,,,,,
529,529,409,I,,,,,,,,,,,,,,,,,,,,,,,,,
530,530,410,C,,,,,,,,,,,,,,,,,,,,,,,,,
531,531,411,A,,,,,,,,,,,,,,,,,,,,,,,,,
532,532,412,S,N,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:14029024-14029024","hg19,16:g.14029024G>A",0.216,,,,,,
533,533,413,D,H,,,,,,,,,,,,,cBioPortal,"msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14029026-14029026","hg19,16:g.14029026G>C",0.790,,,,,,
534,534,414,D,,,,,,,,,,,,,,,,,,,,,,,,,
535,535,415,R,G,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
536,536,415,R,Q,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13935176-13935176","hg38,16:g.13935176G>A",0.312,"prostate, soft_tissue, blood_vessel, central_nervous_system, soft_tissue, striated_muscle, cheek, soft_tissue, striated_muscle, face, soft_tissue, striated_muscle, shoulder, soft_tissue, striated_muscle, vulva","carcinoma, adenocarcinoma, haemangioblastoma, rhabdomyosarcoma, alveolar, rhabdomyosarcoma, embryonal",0.0561318800395194,0.0462538226299694,,
537,537,416,T,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,,,,,,,,,,,,
538,538,417,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,,,,,,,,,,,,
539,539,418,S,F,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,16:14029042-14029042, hg38,16:13935185-13935185","hg19,16:g.14029042C>T, hg38,16:g.13935185C>T",0.107,,malignant_melanoma,,,,
540,540,418,S,Y,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,COSMIC,,,"hg38,16:13935185-13935185","hg38,16:g.13935185C>A",0.127,lung,"carcinoma, adenocarcinoma",,,,
541,541,419,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,,,,,,,,,,,,
542,542,420,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,,,,,,,,,,,,
543,543,421,R,K,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018, luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Cervical Squamous Cell Carcinoma, Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14029051-14029051, hg38,16:13935194-13935194","hg19,16:g.14029051G>A, hg38,16:g.13935194G>A",0.063,"cervix, lung, right_upper_lobe","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,
544,544,421,R,T,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_mind_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Breast, Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14029051-14029051, hg38,16:13935194-13935194","hg19,16:g.14029051G>C, hg38,16:g.13935194G>C",0.264,"breast, lung","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",3.9837780558e-06,,,
545,545,422,D,V,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
546,546,423,Y,C,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 423-426, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 423-426, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 423-426, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
547,547,424,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 415-424, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 423-426, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 423-426, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 423-426, ELM",,,,,,,,,,,,,
548,548,425,T,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 423-426, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 423-426, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 423-426, ELM",,,,,,,,,,,,,
549,549,426,L,I,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 423-426, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 423-426, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 423-426, ELM",,cBioPortal,glioma_mskcc_2019,Diffuse Glioma,"hg19,16:14029065-14029065","hg19,16:g.14029065C>A",0.041,,,,,,
550,550,427,G,E,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM",,cBioPortal,luad_oncosg_2020,Lung Adenocarcinoma,"hg19,16:14029069-14029069","hg19,16:g.14029069G>A",0.658,,,,,,
551,551,428,A,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM",,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, msk_impact_2017, msk_met_2021, pancan_pcawg_2020, ucec_msk_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14029072-14029072, hg38,16:13935215-13935215","hg19,16:g.14029072C>T, hg38,16:g.13935215C>T",0.326,"endometrium, large_intestine, colon, sigmoid","carcinoma, adenocarcinoma, carcinoma, clear_cell_carcinoma",1.59460386054e-05,,,
552,552,429,E,K,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
553,553,430,A,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018, ucec_tcga_pan_can_atlas_2018","Cutaneous Melanoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14029078-14029078, hg38,16:13935221-13935221","hg19,16:g.14029078C>T, hg38,16:g.13935221C>T",0.082,,malignant_melanoma,,,,
554,554,431,F,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 422-431, ELM",,,,,,,,,,,,,
555,555,432,L,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,,,,,,,,,,,,
556,556,433,L,F,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017","Breast, Mixed Cancer Types","hg19,16:14029088-14029088, hg38,16:13935231-13935231","hg19,16:g.14029088G>T, hg38,16:g.13935231G>T",0.049,breast,"carcinoma, ductolobular_carcinoma",,,,
557,557,433,L,W,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
558,558,434,R,K,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
559,559,435,L,F,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,cBioPortal,"coadread_tcga, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,16:14029092-14029092","hg19,16:g.14029092C>T",0.152,,,,,,
560,560,435,L,H,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,cBioPortal,msk_spectrum_tme_2022,Ovary/Fallopian Tube,"hg19,16:14029093-14029093","hg19,16:g.14029093T>A",0.356,,,,,,
561,561,435,L,R,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
562,562,436,Y,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 436-438, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,,,,,,,,,,,,
563,563,437,R,K,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 436-438, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 437-441, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,COSMIC,,,"hg38,16:13935242-13935242","hg38,16:g.13935242G>A",0.062,"skin, extremity","malignant_melanoma, nodular",,,,
564,564,437,R,M,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 436-438, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 437-441, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,COSMIC,,,"hg38,16:13935242-13935242","hg38,16:g.13935242G>T",0.125,lung,"carcinoma, adenocarcinoma",,,,
565,565,437,R,S,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 436-438, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 437-441, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,COSMIC,,,"hg38,16:13935243-13935243","hg38,16:g.13935243G>T",0.047,lung,"carcinoma, adenocarcinoma",,,,
566,566,438,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 436-438, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 438-442, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 437-441, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 432-438, ELM",,,,,,,,,,,,,
567,567,439,T,P,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 438-442, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 437-441, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14029104-14029104, hg38,16:13935247-13935247","hg19,16:g.14029104A>C, hg38,16:g.13935247A>C",0.203,"endometrium, large_intestine","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",3.988608534e-06,,,
568,568,440,F,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 438-442, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 437-441, ELM",,,,,,,,,,,,,
569,569,441,E,K,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 438-442, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 437-441, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,16:14029110-14029110, hg38,16:13935253-13935253","hg19,16:g.14029110G>A, hg38,16:g.13935253G>A",0.154,"urinary_tract, bladder",carcinoma,3.989499637e-06,,,
570,570,441,E,Q,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 438-442, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 437-441, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029110-14029110","hg19,16:g.14029110G>C",0.120,,,,,,
571,571,442,K,N,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 438-442, ELM",,COSMIC,,,"hg38,16:13935258-13935258","hg38,16:g.13935258G>T",0.144,lung,"carcinoma, adenocarcinoma",,,,
572,572,443,D,N,,,,,,,,,,,,,"cBioPortal,COSMIC",ctcl_columbia_2015,Non-Hodgkin Lymphoma,"hg19,16:14029116-14029116, hg38,16:13935259-13935259","hg19,16:g.14029116G>A, hg38,16:g.13935259G>A",0.123,"haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,,,
573,573,444,S,,,,,,,,,,,,,,,,,,,,,,,,,
574,574,445,K,T,,,Ubq,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
575,575,446,A,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
576,576,446,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14029126-14029126, hg38,16:13935269-13935269","hg19,16:g.14029126C>T, hg38,16:g.13935269C>T",0.169,endometrium,"carcinoma, endometrioid_carcinoma",7.9794449498e-06,,,
577,577,447,E,K,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029128-14029128","hg19,16:g.14029128G>A",0.101,,,7.9786173056e-06,,,
578,578,447,E,Q,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
579,579,448,E,Q,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 448-453, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
580,580,449,V,A,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 448-453, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
581,581,449,V,I,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 448-453, ELM",,cBioPortal,egc_mskcc_2020,Esophagus/Stomach,"hg19,16:14029134-14029134","hg19,16:g.14029134G>A",0.099,,,,3.18593092902e-05,,
582,582,450,W,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 448-453, ELM",,,,,,,,,,,,,
583,583,451,M,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 448-453, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14029140-14029140","hg19,16:g.14029140A>G",0.044,,,,,,
584,584,452,K,,,,Ubq,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 448-453, ELM",,,,,,,,,,,,,
585,585,453,F,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 453-455, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 447-453, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 448-453, ELM",,,,,,,,,,,,,
586,586,454,R,K,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 453-455, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,16:14029150-14029150","hg19,16:g.14029150G>A",0.120,,,,,,
587,587,455,K,N,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 453-455, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM",,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,16:14029154-14029154","hg19,16:g.14029154G>T",0.077,,,,,,
588,588,455,K,R,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 453-455, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
589,589,456,E,K,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
590,590,457,D,G,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM",,COSMIC,,,"hg38,16:13935302-13935302","hg38,16:g.13935302A>G",0.046,"haematopoietic_and_lymphoid_tissue, testis","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",1.19726066759e-05,,,
591,591,457,D,N,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 447-457, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 448-457, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029158-14029158","hg19,16:g.14029158G>A",0.087,,,,,,
592,592,458,S,,,,,,,,,,,,,,,,,,,,,,,,,
593,593,459,S,L,,,,,,,,,,,"NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 459-464, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,16:14029165-14029165, hg38,16:13935308-13935308","hg19,16:g.14029165C>T, hg38,16:g.13935308C>T",0.115,lung,"carcinoma, squamous_cell_carcinoma",,,,
594,594,460,K,M,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 460-462, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 460-464, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 459-464, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
595,595,461,R,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 460-462, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 460-464, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 459-464, ELM",,,,,,,,,,,,,
596,596,462,I,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 462-464, ELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 460-462, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 460-464, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 459-464, ELM",,,,,,,,,,,,,
597,597,463,R,K,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 462-464, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 460-464, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 459-464, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14029177-14029177","hg19,16:g.14029177G>A",0.020,,,,,,
598,598,464,K,I,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 462-464, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 460-464, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 459-464, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
599,599,465,S,F,P,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029183-14029183","hg19,16:g.14029183C>T",0.133,,,,,,
600,600,466,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM|SH3 ligand (LIG_SH3_3), 466-472, ELM",,,,,,,,,,,,,
601,601,467,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 467-469, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM|SH3 ligand (LIG_SH3_3), 466-472, ELM",,,,,,,,,,,,,
602,602,468,R,K,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 467-469, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM|SH3 ligand (LIG_SH3_3), 466-472, ELM",,cBioPortal,"msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14029192-14029192","hg19,16:g.14029192G>A",0.093,,,,,,
603,603,468,R,T,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 467-469, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM|SH3 ligand (LIG_SH3_3), 466-472, ELM",,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,16:14029192-14029192","hg19,16:g.14029192G>C",0.056,,,4.0256352452e-06,,,
604,604,469,P,H,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 467-469, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM|SH3 ligand (LIG_SH3_3), 466-472, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,16:14029195-14029195, hg38,16:13935338-13935338","hg19,16:g.14029195C>A, hg38,16:g.13935338C>A",0.075,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,,,
605,605,469,P,L,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 467-469, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 463-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 461-469, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 463-469, ELM|SH3 ligand (LIG_SH3_3), 466-472, ELM",,cBioPortal,"msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14029195-14029195","hg19,16:g.14029195C>T",0.035,,,,,,
606,606,470,K,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 466-472, ELM",,,,,,,,,,,,,
607,607,471,D,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 466-472, ELM",,,,,,,,,,,,,
608,608,472,P,L,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 466-472, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
609,609,473,Q,,,,,,,,,,,,,,,,,,,,,,,,,
610,610,474,N,,,,,,,,,,,,,,,,,,,,,,,,,
611,611,475,K,,,,,,,,,,,,,,,,,,,,,,,,,
612,612,476,E,Q,,,,,,,,,,,,,cBioPortal,brca_cptac_2020,Invasive Breast Carcinoma,"hg19,16:14029215-14029215","hg19,16:g.14029215G>C",0.072,,,,,,
613,613,477,R,L,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:14029219-14029219, hg38,16:13935362-13935362","hg19,16:g.14029219G>T, hg38,16:g.13935362G>T",0.047,skin,malignant_melanoma,,,,
614,614,477,R,Q,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,"cBioPortal,COSMIC","metastatic_solid_tumors_mich_2017, stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,16:14029219-14029219, hg38,16:13935362-13935362","hg19,16:g.14029219G>A, hg38,16:g.13935362G>A",0.116,stomach,"carcinoma, adenocarcinoma",1.23053700635e-05,3.18714941356e-05,,
615,615,477,R,W,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,"cBioPortal,COSMIC","appendiceal_msk_2022, crc_apc_impact_2020, msk_impact_2017, msk_met_2021, stad_tcga_pan_can_atlas_2018","Appendiceal Adenocarcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,16:14029218-14029218, hg38,16:13935361-13935361","hg19,16:g.14029218C>T, hg38,16:g.13935361C>T",0.109,"large_intestine, appendix, stomach, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, adenocarcinoma, carcinoma, nasopharyngeal_carcinoma",4.1046859094e-06,,,
616,616,478,A,D,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,cBioPortal,glioma_mskcc_2019,Diffuse Glioma,"hg19,16:14029222-14029222","hg19,16:g.14029222C>A",0.064,,,,,,
617,617,478,A,T,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",utuc_igbmc_2021,Upper Tract Urothelial Carcinoma,"hg19,16:14029221-14029221","hg19,16:g.14029221G>A",0.033,,,,,,
618,618,479,S,Y,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029225-14029225","hg19,16:g.14029225C>A",0.110,,,,,,
619,619,480,T,A,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14029227-14029227, hg38,16:13935370-13935370","hg19,16:g.14029227A>G, hg38,16:g.13935370A>G",0.029,lung,"carcinoma, small_cell_carcinoma",,,,
620,620,481,K,E,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14029230-14029230, hg38,16:13935373-13935373","hg19,16:g.14029230A>G, hg38,16:g.13935373A>G",0.123,lung,"carcinoma, adenocarcinoma",,,,
621,621,482,E,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM",,,,,,,,,,,,,
622,622,483,R,G,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 483-487, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
623,623,483,R,I,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 483-487, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14029237-14029237, hg38,16:13935380-13935380","hg19,16:g.14029237G>T, hg38,16:g.13935380G>T",0.026,"large_intestine, colon, descending","carcinoma, adenocarcinoma",,,,
624,624,483,R,T,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 483-487, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14029237-14029237, hg38,16:13935380-13935380","hg19,16:g.14029237G>C, hg38,16:g.13935380G>C",0.012,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,
625,625,484,T,I,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 483-487, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,16:14029240-14029240, hg38,16:13935383-13935383","hg19,16:g.14029240C>T, hg38,16:g.13935383C>T",0.118,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,,,
626,626,485,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 483-487, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 477-485, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM",,,,,,,,,,,,,
627,627,486,K,E,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 483-487, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14029245-14029245, hg38,16:13935388-13935388","hg19,16:g.14029245A>G, hg38,16:g.13935388A>G",0.084,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,,,
628,628,487,K,E,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 483-487, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 487-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 487-492, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
629,629,487,K,N,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 483-487, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 487-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 487-492, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14029250-14029250, hg38,16:13935393-13935393","hg19,16:g.14029250G>C, hg38,16:g.13935393G>C",0.081,"lung, prostate","carcinoma, adenocarcinoma",,,,
630,630,488,K,R,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 488-494, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 487-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 487-492, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 488-493, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
631,631,489,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 489-491, ELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 489-491, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 488-494, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 487-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 487-492, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 488-493, ELM",,,,,,,,,,,,,
632,632,490,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 489-491, ELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 489-491, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 490-494, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 488-494, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 487-491, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 490-495, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 487-492, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 488-493, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, coad_silu_2022, crc_apc_impact_2020, crc_msk_2017, msk_met_2021, tmb_mskcc_2018","Colon Adenocarcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14029258-14029258, hg38,16:13935401-13935401","hg19,16:g.14029258G>A, hg38,16:g.13935401G>A",0.290,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,,,
633,633,490,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 489-491, ELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 489-491, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 490-494, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 488-494, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 487-491, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 490-495, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 487-492, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 485-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 483-490, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 488-493, ELM",,cBioPortal,"glioma_mskcc_2019, msk_met_2021","Diffuse Glioma, Mixed Cancer Types","hg19,16:14029257-14029257","hg19,16:g.14029257C>T",0.150,,,4.0490092074e-06,,,
634,634,491,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 489-491, ELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 489-491, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 490-494, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 488-494, ELM|USP7 binding motif (DOC_USP7_UBL2_3), 487-491, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 490-495, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 487-492, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtC_3), 486-491, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 488-493, ELM",,,,,,,,,,,,,
635,635,492,L,M,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 490-494, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 488-494, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 490-495, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoCore_2), 487-492, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 488-493, ELM",,cBioPortal,"angs_painter_2020, angs_project_painter_2018",Angiosarcoma,"hg19,16:14029263-14029263","hg19,16:g.14029263T>A",0.162,,,,,,
636,636,493,T,P,P,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 490-494, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 488-494, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 490-495, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 493-499, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 486-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 487-493, ELM|NLS classical Nuclear Localization Signals (TRG_NLS_MonoExtN_4), 488-493, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
637,637,494,L,S,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 490-494, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 486-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 487-494, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 488-494, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 490-495, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 493-499, ELM",,COSMIC,,,"hg38,16:13935413-13935413","hg38,16:g.13935413T>C",0.257,breast,"carcinoma, basal_(triple-negative)_carcinoma",,,,
638,638,495,T,I,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 486-495, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 487-495, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 490-495, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 493-499, ELM|SH3 ligand (LIG_SH3_3), 495-501, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
639,639,496,Q,E,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 493-499, ELM|SH3 ligand (LIG_SH3_3), 495-501, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14029275-14029275","hg19,16:g.14029275C>G",0.136,,,,,,
640,640,496,Q,H,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 493-499, ELM|SH3 ligand (LIG_SH3_3), 495-501, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",mixed_pipseq_2017,Mixed Cancer Types,"hg19,16:14029277-14029277","hg19,16:g.14029277A>T",0.330,,,0.0006948881789137,0.0020058583800306,,
641,641,497,M,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 493-499, ELM|SH3 ligand (LIG_SH3_3), 495-501, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
642,642,498,V,A,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 493-499, ELM|SH3 ligand (LIG_SH3_3), 495-501, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,16:14029282-14029282","hg19,16:g.14029282T>C",0.056,,,3.5937612305e-05,,,
643,643,499,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 493-499, ELM|SH3 ligand (LIG_SH3_3), 495-501, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,,,,,,,,,,,,
644,644,500,K,,,,,,,Ac,,,,,"SH3 ligand (LIG_SH3_3), 495-501, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,,,,,,,,,,,,
645,645,501,P,L,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 495-501, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,16:14029291-14029291, hg38,16:13935434-13935434","hg19,16:g.14029291C>T, hg38,16:g.13935434C>T",0.091,,malignant_melanoma,,,,
646,646,502,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,,,,,,,,,,,,
647,647,503,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,,,,,,,,,,,,
648,648,504,L,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,,,,,,,,,,,,
649,649,505,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,,,,,,,,,,,,
650,650,506,E,K,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,16:14029305-14029305","hg19,16:g.14029305G>A",0.191,,,,,,
651,651,507,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 499-507, ELM",,,,,,,,,,,,,
652,652,508,G,E,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
653,653,508,G,R,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
654,654,509,D,,,,,,,,,,,,,,,,,,,,,,,,,
655,655,510,V,,,,,,,,,,,,,,,,,,,,,,,,,
656,656,511,E,G,,,,,,,,,,,,,cBioPortal,"msk_met_2021, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14029321-14029321","hg19,16:g.14029321A>G",0.089,,,3.9818427968e-06,,,
657,657,512,E,,,,,,,,,,,,,,,,,,,,,,,,,
658,658,513,G,E,,,,,,,,,,,,,cBioPortal,"glioma_msk_2018, msk_met_2021","Diffuse Glioma, Mixed Cancer Types","hg19,16:14029327-14029327","hg19,16:g.14029327G>A",0.096,,,3.9813037974e-06,,,
659,659,514,Y,C,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 514-516, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",egc_msk_tp53_ccr_2022,Esophagogastric Adenocarcinoma,"hg19,16:14029330-14029330","hg19,16:g.14029330A>G",0.088,,,3.98076494379e-05,,,
660,660,514,Y,N,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 514-516, ELM",,cBioPortal,egc_tmucih_2015,Esophagogastric Adenocarcinoma,"hg19,16:14029329-14029329","hg19,16:g.14029329T>A",0.056,,,,,,
661,661,515,R,C,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 515-517, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 514-516, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14029332-14029332, hg38,16:13935475-13935475","hg19,16:g.14029332C>T, hg38,16:g.13935475C>T",0.086,skin,"carcinoma, Merkel_cell_carcinoma",,,,
662,662,515,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 515-517, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 514-516, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
663,663,516,R,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 515-517, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 514-516, ELM",,"cBioPortal,COSMIC","luad_msk_npjpo_2021, luad_mskcc_2023_met_organotropism, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14029336-14029336, hg38,16:13935479-13935479","hg19,16:g.14029336G>T, hg38,16:g.13935479G>T",0.026,lung,"carcinoma, adenocarcinoma",,,,
664,664,516,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 515-517, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 514-516, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, crc_msk_2017, cscc_ucsf_2021, mixed_impact_subset_2022, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types","hg19,16:14029336-14029336, hg38,16:13935479-13935479","hg19,16:g.14029336G>A, hg38,16:g.13935479G>A",0.031,"large_intestine, large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,,,
665,665,517,E,K,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 515-517, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017","Breast, Mixed Cancer Types","hg19,16:14029338-14029338, hg38,16:13935481-13935481","hg19,16:g.14029338G>A, hg38,16:g.13935481G>A",0.053,breast,"carcinoma, carcinoma, ER-positive_carcinoma",1.1942770245e-05,9.55170657157e-05,,
666,666,518,I,M,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 518-523, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
667,667,519,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 518-523, ELM",,,,,,,,,,,,,
668,668,520,S,N,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 518-523, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13935491-13935491","hg38,16:g.13935491G>A",0.097,"skin, head_neck","malignant_melanoma, nodular",,,,
669,669,521,S,R,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 518-523, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13935495-13935495","hg38,16:g.13935495C>G",0.110,prostate,carcinoma,0.0008797280406347,0.000605249745158,,
670,670,522,P,L,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 518-523, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,16:14029354-14029354, hg38,16:13935497-13935497","hg19,16:g.14029354C>T, hg38,16:g.13935497C>T",0.056,liver,carcinoma,,,,
671,671,523,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 518-523, ELM",,,,,,,,,,,,,
672,672,524,S,N,P,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,COSMIC,,,"hg38,16:13935503-13935503","hg38,16:g.13935503G>A",0.095,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",,,,
673,673,525,C,W,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13935507-13935507","hg38,16:g.13935507C>G",0.136,"upper_aerodigestive_tract, pharynx","carcinoma, squamous_cell_carcinoma",2.78615836524e-05,,,
674,674,526,P,L,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
675,675,527,E,D,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
676,676,527,E,K,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,cBioPortal,paired_bladder_2022,Bladder/Urinary Tract,"hg19,16:14029368-14029368","hg19,16:g.14029368G>A",0.143,,,,,,
677,677,528,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,,,,,,,,,,,,
678,678,529,I,M,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pub",Lung Adenocarcinoma,"hg19,16:14029376-14029376, hg38,16:13935519-13935519","hg19,16:g.14029376T>G, hg38,16:g.13935519T>G",0.089,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,,,
679,679,529,I,N,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029375-14029375","hg19,16:g.14029375T>A",0.066,,,,,,
680,680,530,K,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,,,,,,,,,,,,
681,681,531,H,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,,,,,,,,,,,,
682,682,532,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 524-532, ELM",,,,,,,,,,,,,
683,683,533,E,G,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029387-14029387","hg19,16:g.14029387A>G",0.041,,,,,,
684,684,533,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:14029386-14029386, hg38,16:13935529-13935529","hg19,16:g.14029386G>A, hg38,16:g.13935529G>A",0.076,skin,malignant_melanoma,,,,
685,685,534,F,,,,,,,,,,,,,,,,,,,,,,,,,
686,686,535,D,H,,,,,,,,,,,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:14029392-14029392","hg19,16:g.14029392G>C",0.119,,,7.9558925318e-06,,,
687,687,535,D,N,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029392-14029392","hg19,16:g.14029392G>A",0.130,,,,,,
688,688,536,V,A,,,,,,,,,,,,,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,16:14029396-14029396, hg38,16:13935539-13935539","hg19,16:g.14029396T>C, hg38,16:g.13935539T>C",0.095,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
689,689,536,V,L,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14029395-14029395","hg19,16:g.14029395G>T",0.038,,,,,,
690,690,537,N,H,,,,,,,,,,,,,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,16:14029398-14029398","hg19,16:g.14029398A>C",0.125,,,,,,
691,691,538,L,,,,,,,,,,,,,,,,,,,,,,,,,
692,692,539,S,,,,,,,,,,,,,,,,,,,,,,,,,
693,693,540,S,L,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, cellline_ccle_broad, crc_msk_2017, lymphoma_cellline_msk_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018, ucec_tcga_pan_can_atlas_2018, ucs_tcga, ucs_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Lymphoid, Mixed Cancer Types, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,16:14029408-14029408, hg38,16:13935551-13935551","hg19,16:g.14029408C>T, hg38,16:g.13935551C>T",0.298,"endometrium, large_intestine, caecum","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",1.98895730902e-05,9.5523148443e-05,,
694,694,541,D,G,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
695,695,541,D,H,,,,,,,,,,,,,COSMIC,,,"hg38,16:13935553-13935553","hg38,16:g.13935553G>C",0.364,cervix,"carcinoma, squamous_cell_carcinoma",,,,
696,696,541,D,N,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:14029410-14029410, hg38,16:13935553-13935553","hg19,16:g.14029410G>A, hg38,16:g.13935553G>A",0.194,"large_intestine, rectum","carcinoma, adenocarcinoma",,,,
697,697,541,D,Y,,,,,,,,,,,,,cBioPortal,luad_mskcc_2023_met_organotropism,Lung Adenocarcinoma,"hg19,16:14029410-14029410","hg19,16:g.14029410G>T",0.389,,,,,,
698,698,542,A,,,,,,,,,,,,,,,,,,,,,,,,,
699,699,543,A,,,,,,,,,,,,,,,,,,,,,,,,,
700,700,544,F,,,,,,,,,,,,,,,,,,,,,,,,,
701,701,545,G,R,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","mel_mskimpact_2020, msk_met_2021, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Cutaneous Melanoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14029422-14029422, hg38,16:13935565-13935565","hg19,16:g.14029422G>A, hg38,16:g.13935565G>A",0.491,endometrium,"carcinoma, endometrioid_carcinoma",1.98905225638e-05,0.00012745347948,,
702,702,546,I,,,,,,,,,,,,,,,,,,,,,,,,,
703,703,547,L,,,,,,,,,,,,,,,,,,,,,,,,,
704,704,548,K,Q,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14029431-14029431, hg38,16:13935574-13935574","hg19,16:g.14029431A>C, hg38,16:g.13935574A>C",0.123,lung,"carcinoma, adenocarcinoma",,,,
705,705,549,E,D,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
706,706,549,E,K,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM",,"cBioPortal,COSMIC",cscc_dfarber_2015,Cutaneous Squamous Cell Carcinoma,"hg19,16:14029434-14029434, hg38,16:13935577-13935577","hg19,16:g.14029434G>A, hg38,16:g.13935577G>A",0.094,skin,"carcinoma, squamous_cell_carcinoma",,,,
707,707,550,P,S,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","cscc_dfarber_2015, hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub","Cutaneous Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma","hg19,16:14029437-14029437, hg38,16:13935580-13935580","hg19,16:g.14029437C>T, hg38,16:g.13935580C>T",0.308,"skin, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",1.19371627752e-05,,,
708,708,551,L,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM",,,,,,,,,,,,,
709,709,552,T,A,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
710,710,552,T,I,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
711,711,553,I,M,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 553-558, ELM",,COSMIC,,,"hg38,16:13935591-13935591","hg38,16:g.13935591C>G",0.069,"biliary_tract, gallbladder","carcinoma, small_cell_carcinoma",,,,
712,712,553,I,T,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 553-558, ELM",,cBioPortal,ccrcc_dfci_2019,Renal Clear Cell Carcinoma,"hg19,16:14029447-14029447","hg19,16:g.14029447T>C",0.157,,,,,,
713,713,553,I,V,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 553-558, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","lung_msk_mind_2020, msk_met_2021","Lung, Mixed Cancer Types","hg19,16:14029446-14029446, hg38,16:13935589-13935589","hg19,16:g.14029446A>G, hg38,16:g.13935589A>G",0.098,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",3.9793076005e-06,,,
714,714,554,I,M,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 553-558, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
715,715,555,H,Y,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 549-555, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 553-558, ELM",,cBioPortal,"mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14029452-14029452","hg19,16:g.14029452C>T",0.462,,,,,,
716,716,556,P,L,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 553-558, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021, pptc_2019, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14029456-14029456","hg19,16:g.14029456C>T",0.495,,,,,,
717,717,557,L,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 553-558, ELM",,,,,,,,,,,,,
718,718,558,L,M,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaLyEn_6), 553-558, ELM",,cBioPortal,"coad_silu_2022, msk_met_2021","Colon Adenocarcinoma, Mixed Cancer Types","hg19,16:14029461-14029461","hg19,16:g.14029461C>A",0.097,,,,,,
719,719,559,G,D,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",acc_2019,Adenoid Cystic Carcinoma,"hg19,16:14029465-14029465","hg19,16:g.14029465G>A",0.460,,,4.38082949015e-05,6.36658814541e-05,,
720,720,559,G,N,,,,,,,,,,,,,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14029464-14029465, hg38,16:13935607-13935608","hg19,16:g.14029464_14029465delinsAA, hg38,16:g.13935607_13935608delinsAA",,skin,malignant_melanoma,,,,
721,721,560,C,R,,,,,,,,,,,,,COSMIC,,,"hg38,16:13935610-13935610","hg38,16:g.13935610T>C",0.237,ovary,"carcinoma, mixed_adenosquamous_carcinoma",,,,
722,722,561,S,C,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
723,723,561,S,I,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:14029471-14029471, hg38,16:13935614-13935614","hg19,16:g.14029471G>T, hg38,16:g.13935614G>T",0.190,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
724,724,562,D,N,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv","egc_msk_tp53_ccr_2022, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Esophagogastric Adenocarcinoma","hg19,16:14029473-14029473","hg19,16:g.14029473G>A",0.354,,,7.17160046217e-05,,,
725,725,563,P,H,,,,,,,,,,,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:14029477-14029477, hg38,16:13935620-13935620","hg19,16:g.14029477C>A, hg38,16:g.13935620C>A",0.428,skin,malignant_melanoma,,,,
726,726,563,P,L,,,,,,,,,,,,,COSMIC,,,"hg38,16:13935620-13935620","hg38,16:g.13935620C>T",0.404,lung,"carcinoma, non_small_cell_carcinoma",3.9841907312e-06,,,
727,727,564,Y,C,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
728,728,565,A,D,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14029483-14029483","hg19,16:g.14029483C>A",0.210,,,,,,
729,729,565,A,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","bcc_unige_2016, difg_glass_2019","Basal Cell Carcinoma, Diffuse Glioma","hg19,16:14029483-14029483, hg38,16:13935626-13935626","hg19,16:g.14029483C>T, hg38,16:g.13935626C>T",0.202,"skin, neck","carcinoma, basal_cell_carcinoma",3.9858105146e-06,,,
730,730,566,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,,,,,,,,,,,,
731,731,567,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,,,,,,,,,,,,
732,732,568,R,S,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029493-14029493","hg19,16:g.14029493G>C",0.407,,,,,,
733,733,569,V,L,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14029494-14029494","hg19,16:g.14029494G>T",0.210,,,,,,
734,734,570,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,,,,,,,,,,,,
735,735,571,H,R,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,COSMIC,,,"hg38,16:13935644-13935644","hg38,16:g.13935644A>G",0.239,"oesophagus, lower_third","carcinoma, squamous_cell_carcinoma",,,,
736,736,571,H,Y,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 565-571, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
737,737,572,E,,,,,,,,,,,,,,,,,,,,,,,,,
738,738,573,V,,,,,,,,,,,,,,,,,,,,,,,,,
739,739,574,E,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 574-578, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM",,,,,,,,,,,,,
740,740,575,P,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 574-578, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM",,,,,,,,,,,,,
741,741,576,R,S,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 574-578, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,16:14029517-14029517","hg19,16:g.14029517A>T",0.093,,,7.99776062702e-05,3.1841049481e-05,,
742,742,576,R,T,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 574-578, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM",,"COSMIC,Manual annotations from ERCC4_icope_sentieon_input.csv,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13935659-13935659","hg38,16:g.13935659G>C",0.274,prostate,carcinoma,0.0006877029123419,0.0004139072847682,,
743,743,577,Y,,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 574-578, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 577-580, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 577-580, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 577-580, ELM",,,,,,,,,,,,,
744,744,578,V,L,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 574-578, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 577-580, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 577-580, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 577-580, ELM",,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14029521-14029521, hg38,16:13935664-13935664","hg19,16:g.14029521G>T, hg38,16:g.13935664G>T",0.445,lung,"carcinoma, adenocarcinoma",,,,
745,745,578,V,M,,,,,,,,,,,"Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 574-578, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 577-580, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 577-580, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 577-580, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, coadread_tcga_pan_can_atlas_2018, msk_ch_2020, msk_met_2021, paad_tcga, paad_tcga_pan_can_atlas_2018, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021","Colorectal Adenocarcinoma, Mixed Cancer Types, Pancreatic Adenocarcinoma, Prostate Adenocarcinoma","hg19,16:14029521-14029521, hg38,16:13935664-13935664","hg19,16:g.14029521G>A, hg38,16:g.13935664G>A",0.604,"large_intestine, caecum","carcinoma, adenocarcinoma",8.0035856064e-06,,,
746,746,579,V,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 577-580, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 577-580, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 577-580, ELM",,,,,,,,,,,,,
747,747,580,L,I,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 577-580, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 577-580, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 577-580, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018",Invasive Breast Carcinoma,"hg19,16:14029527-14029527, hg38,16:13935670-13935670","hg19,16:g.14029527C>A, hg38,16:g.13935670C>A",0.373,breast,carcinoma,,,,
748,748,580,L,P,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 577-580, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 577-580, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 577-580, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
749,749,580,L,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 577-580, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 577-580, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 577-580, ELM",,"cBioPortal,COSMIC","egc_msk_2017, msk_impact_2017, msk_met_2021","Esophagogastric Adenocarcinoma, Mixed Cancer Types","hg19,16:14029527-14029527, hg38,16:13935670-13935670","hg19,16:g.14029527C>G, hg38,16:g.13935670C>G",0.353,"oesophagus, stomach","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,,,
750,750,581,Y,H,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 581-585, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14029530-14029530, hg38,16:13935673-13935673","hg19,16:g.14029530T>C, hg38,16:g.13935673T>C",0.784,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,
751,751,582,D,E,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 581-585, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
752,752,583,A,T,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 581-585, ELM",,"cBioPortal,COSMIC","ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub",High-Grade Serous Ovarian Cancer,"hg19,16:14029536-14029536, hg38,16:13935679-13935679","hg19,16:g.14029536G>A, hg38,16:g.13935679G>A",0.277,ovary,"carcinoma, serous_carcinoma",,,,
753,753,584,E,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 581-585, ELM",,,,,,,,,,,,,
754,754,585,L,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 574-585, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 581-585, ELM",,,,,,,,,,,,,
755,755,586,T,,,,,,,,,,,,,,,,,,,,,,,,,
756,756,587,F,,,,,,,,,,,,,,,,,,,,,,,,,
757,757,588,V,A,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv","mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14029552-14029552","hg19,16:g.14029552T>C",0.696,,,2.809710359e-05,0.0001592356687898,,
758,758,588,V,I,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
759,759,589,R,G,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
760,760,589,R,Q,,,,,,,,,,,,,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14029555-14029555, hg38,16:13935698-13935698","hg19,16:g.14029555G>A, hg38,16:g.13935698G>A",0.809,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",4.0141619634e-06,,,
761,761,589,R,W,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, gbm_tcga_pan_can_atlas_2018, lgg_tcga_pan_can_atlas_2018, mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Diffuse Glioma, Glioblastoma Multiforme, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,16:14029554-14029554, hg38,16:13935697-13935697","hg19,16:g.14029554C>T, hg38,16:g.13935697C>T",0.750,breast,carcinoma,6.42296853548e-05,6.37023824691e-05,,
762,762,590,Q,,,,,,,,,,,,,,,,,,,,,,,,,
763,763,591,L,V,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
764,764,592,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC",escc_ucla_2014,Esophageal Squamous Cell Carcinoma,"hg19,16:14029563-14029563, hg38,16:13935706-13935706","hg19,16:g.14029563G>A, hg38,16:g.13935706G>A",0.777,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,
765,765,593,I,,,,,,,,,,,,,,,,,,,,,,,,,
766,766,594,Y,,,,,,,,,,,,,,,,,,,,,,,,,
767,767,595,R,M,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM",,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14029573-14029573, hg38,16:13935716-13935716","hg19,16:g.14029573G>T, hg38,16:g.13935716G>T",0.387,lung,"carcinoma, adenocarcinoma",,,,
768,768,596,A,E,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
769,769,596,A,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,"cBioPortal,COSMIC","esca_broad, mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Esophageal Adenocarcinoma, Mixed Cancer Types","hg19,16:14029575-14029575, hg38,16:13935718-13935718","hg19,16:g.14029575G>A, hg38,16:g.13935718G>A",0.412,oesophagus,"carcinoma, adenocarcinoma",,,,
770,770,596,A,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, msk_impact_2017, msk_met_2021, ucec_ccr_msk_2022, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14029576-14029576, hg38,16:13935719-13935719","hg19,16:g.14029576C>T, hg38,16:g.13935719C>T",0.474,endometrium,"carcinoma, endometrioid_carcinoma",,,,
771,771,597,S,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,,,,,,,,,,,,
772,772,598,R,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
773,773,599,P,S,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|SH3 ligand (LIG_SH3_2), 599-604, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,COSMIC,,,"hg38,16:13935727-13935727","hg38,16:g.13935727C>T",0.432,"skin, mucosal, anorectal",malignant_melanoma,,,,
774,774,600,G,E,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|SH3 ligand (LIG_SH3_2), 599-604, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
775,775,600,G,W,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|SH3 ligand (LIG_SH3_2), 599-604, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,16:14029587-14029587","hg19,16:g.14029587G>T",0.498,,,,,,
776,776,601,K,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|SH3 ligand (LIG_SH3_2), 599-604, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
777,777,602,P,L,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 602-608, ELM|SH3 ligand (LIG_SH3_2), 599-604, ELM|SH3 ligand (LIG_SH3_3), 596-602, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:14029594-14029594, hg38,16:13935737-13935737","hg19,16:g.14029594C>T, hg38,16:g.13935737C>T",0.371,skin,malignant_melanoma,,3.18451054073e-05,,
778,778,603,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 602-608, ELM|SH3 ligand (LIG_SH3_2), 599-604, ELM",,,,,,,,,,,,,
779,779,604,R,G,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 602-608, ELM|SH3 ligand (LIG_SH3_2), 599-604, ELM",,COSMIC,,,"hg38,16:13935742-13935742","hg38,16:g.13935742A>G",0.636,gastrointestinal_tract_(site_indeterminate),carcinoma,,,,
780,780,604,R,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 602-608, ELM|SH3 ligand (LIG_SH3_2), 599-604, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
781,781,605,V,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 595-605, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 602-608, ELM",,,,,,,,,,,,,
782,782,606,Y,F,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 602-608, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 606-609, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 606-609, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
783,783,607,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 598-607, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 598-607, ELM|PP1-docking motif RVXF (DOC_PP1_RVXF_1), 602-608, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 606-609, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 606-609, ELM",,,,,,,,,,,,,
784,784,608,L,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 602-608, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 606-609, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 606-609, ELM",,,,,,,,,,,,,
785,785,609,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 606-609, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 606-609, ELM",,,,,,,,,,,,,
786,786,610,Y,C,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:14031640-14031640, hg38,16:13937783-13937783","hg19,16:g.14031640A>G, hg38,16:g.13937783A>G",0.707,large_intestine,"carcinoma, adenocarcinoma",,,,
787,787,611,G,E,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14031643-14031643","hg19,16:g.14031643G>A",0.376,,,,,,
788,788,611,G,R,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","brca_mapk_hp_msk_2021, breast_ink4_msk_2021, lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub","Breast, Diffuse Glioma, Invasive Breast Carcinoma","hg19,16:14031642-14031642, hg38,16:13937785-13937785","hg19,16:g.14031642G>A, hg38,16:g.13937785G>A",0.540,"biliary_tract, bile_duct, central_nervous_system, brain","carcinoma, glioma",7.9570953419e-06,3.1843077315e-05,,
789,789,612,G,,,,,,,,,,,,,,,,,,,,,,,,,
790,790,613,S,L,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 613-616, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:14031649-14031649, hg38,16:13937792-13937792","hg19,16:g.14031649C>T, hg38,16:g.13937792C>T",0.539,", large_intestine, colon","carcinoma, adenocarcinoma, malignant_melanoma",,,,
791,791,614,T,S,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 613-616, ELM",,COSMIC,,,"hg38,16:13937795-13937795","hg38,16:g.13937795C>G",0.293,skin,malignant_melanoma,,,,
792,792,615,E,D,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 613-616, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
793,793,615,E,G,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 613-616, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,COSMIC,,,"hg38,16:13937798-13937798","hg38,16:g.13937798A>G",0.742,"skin, mucosal, anorectal",malignant_melanoma,,,,
794,794,616,E,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 613-616, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, lung_msk_2017, lung_msk_pdx, msk_impact_2017, msk_met_2021","Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14031657-14031657, hg38,16:13937800-13937800","hg19,16:g.14031657G>A, hg38,16:g.13937800G>A",0.613,lung,"carcinoma, adenocarcinoma",,,,
795,795,617,Q,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,,,,,,,,,,,,
796,796,618,R,C,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 618-622, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14031663-14031663","hg19,16:g.14031663C>T",0.389,,,1.1933648912e-05,3.1847133758e-05,,
797,797,618,R,H,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 618-622, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","acc_2019, coadread_dfci_2016, msk_met_2021","Adenoid Cystic Carcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14031664-14031664, hg38,16:13937807-13937807","hg19,16:g.14031664G>A, hg38,16:g.13937807G>A",0.320,"large_intestine, liver, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, combined_hepatocellular-cholangiocarcinoma",7.16064509456e-05,,,
798,798,618,R,L,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 618-622, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
799,799,619,Y,C,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 618-622, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 619-622, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
800,800,620,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 618-622, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 619-622, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,,,,,,,,,,,,
801,801,621,T,A,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 618-622, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 619-622, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
802,802,621,T,S,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 618-622, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 619-622, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_4), 615-621, ELM",,COSMIC,,,"hg38,16:13937815-13937815","hg38,16:g.13937815A>T",0.240,prostate,carcinoma,,,,
803,803,622,A,S,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 618-622, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 619-622, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14031675-14031675","hg19,16:g.14031675G>T",0.054,,,,,,
804,804,623,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 623-625, ELM",,,,,,,,,,,,,
805,805,624,R,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 623-625, ELM",,COSMIC,,,"hg38,16:13937825-13937825","hg38,16:g.13937825G>T",0.421,placenta,choriocarcinoma,,,,
806,806,624,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 623-625, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","coadread_dfci_2016, msk_met_2021, ucec_ccr_msk_2022","Colorectal Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14031682-14031682, hg38,16:13937825-13937825","hg19,16:g.14031682G>A, hg38,16:g.13937825G>A",0.226,"haematopoietic_and_lymphoid_tissue, large_intestine","carcinoma, adenocarcinoma, lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia",7.56044375826e-05,,,
807,807,624,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 623-625, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",msk_impact_2017,Mixed Cancer Types,"hg19,16:14031681-14031681, hg38,16:13937824-13937824","hg19,16:g.14031681C>T, hg38,16:g.13937824C>T",0.430,"liver, penis","carcinoma, squamous_cell_carcinoma, other, neoplasm",1.98951129645e-05,3.18572793883e-05,,
808,808,625,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 623-625, ELM",,,,,,,,,,,,,
809,809,626,E,K,,,,,,,,,,,,,cBioPortal,blca_bcan_hcrn_2022,Bladder Urothelial Carcinoma,"hg19,16:14031687-14031687","hg19,16:g.14031687G>A",0.693,,,,,,
810,810,626,E,Q,,,,,,,,,,,,,COSMIC,,,"hg38,16:13937830-13937830","hg38,16:g.13937830G>C",0.626,lung,"carcinoma, non_small_cell_carcinoma",,,,
811,811,627,K,M,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 627-631, ELM",,COSMIC,,,"hg38,16:13937834-13937834","hg38,16:g.13937834A>T",0.701,thyroid,"carcinoma, medullary_carcinoma",,,,
812,812,628,E,A,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 627-631, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
813,813,628,E,K,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 627-631, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,COSMIC,,,"hg38,16:13937836-13937836","hg38,16:g.13937836G>A",0.079,"skin, head_neck","malignant_melanoma, superficial_spreading",,,,
814,814,629,A,T,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 627-631, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,16:14031696-14031696, hg38,16:13937839-13937839","hg19,16:g.14031696G>A, hg38,16:g.13937839G>A",0.601,,malignant_melanoma,,,,
815,815,630,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 627-631, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,,,,,,,,,,,,
816,816,631,E,Q,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 627-631, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,"cBioPortal,COSMIC","blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, cfdna_msk_2019","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,16:14031702-14031702, hg38,16:13937845-13937845","hg19,16:g.14031702G>C, hg38,16:g.13937845G>C",0.347,"urinary_tract, bladder",carcinoma,,,,
817,817,632,K,,,,Ubq,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,,,,,,,,,,,,
818,818,633,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,,,,,,,,,,,,
819,819,634,I,M,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,COSMIC,,,"hg38,16:13937856-13937856","hg38,16:g.13937856A>G",0.622,large_intestine,"carcinoma, adenocarcinoma",3.984794026e-06,,,
820,820,635,R,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14031715-14031715","hg19,16:g.14031715G>A",0.103,,,,,,
821,821,635,R,S,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,16:14038580-14038580","hg19,16:g.14038580G>T",0.373,,,,,,
822,822,636,E,Q,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14038581-14038581","hg19,16:g.14038581G>C",0.204,,,,,,
823,823,637,K,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,,,,,,,,,,,,
824,824,638,A,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 628-638, ELM",,,,,,,,,,,,,
825,825,639,S,R,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
826,826,640,M,I,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM",,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14038595-14038595, hg38,16:13944738-13944738","hg19,16:g.14038595G>C, hg38,16:g.13944738G>C",0.328,lung,"carcinoma, adenocarcinoma",7.9561457248e-06,,,
827,827,641,V,L,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
828,828,642,V,F,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 632-642, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 635-642, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
829,829,643,P,,,,,,,,,,,,,,,,,,,,,,,,,
830,830,644,E,K,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14038605-14038605","hg19,16:g.14038605G>A",0.307,,,,,,
831,831,645,E,K,,,,,,,,,,,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,16:14038608-14038608","hg19,16:g.14038608G>A",0.311,,,,,,
832,832,646,R,I,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14038612-14038612","hg19,16:g.14038612G>T",0.341,,,,,,
833,833,646,R,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,cBioPortal,cfdna_msk_2019,Mixed Cancer Types,"hg19,16:14038612-14038612","hg19,16:g.14038612G>A",0.200,,,,,,
834,834,646,R,S,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14038613-14038613","hg19,16:g.14038613A>T",0.261,,,,,,
835,835,646,R,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,COSMIC,,,"hg38,16:13944755-13944755","hg38,16:g.13944755G>C",0.280,pancreas,,,,,
836,836,647,E,D,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,cBioPortal,brca_mbcproject_2022,Invasive Breast Carcinoma,"hg19,16:14038616-14038616","hg19,16:g.14038616A>C",0.061,,,,,,
837,837,648,G,D,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14038618-14038618, hg38,16:13944761-13944761","hg19,16:g.14038618G>A, hg38,16:g.13944761G>A",0.383,endometrium,"carcinoma, endometrioid_carcinoma",7.957665221e-06,,,
838,838,648,G,S,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",acc_2019,Adenoid Cystic Carcinoma,"hg19,16:14038617-14038617","hg19,16:g.14038617G>A",0.423,,,3.58100634236e-05,3.1847133758e-05,,
839,839,649,R,I,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,16:14038621-14038621","hg19,16:g.14038621G>T",0.281,,,,,,
840,840,649,R,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,cBioPortal,"luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, lung_msk_pdx","Lung, Lung Adenocarcinoma","hg19,16:14038621-14038621","hg19,16:g.14038621G>A",0.136,,,,,,
841,841,649,R,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018",Breast,"hg19,16:14038621-14038621, hg38,16:13944764-13944764","hg19,16:g.14038621G>C, hg38,16:g.13944764G>C",0.203,"breast, lung","carcinoma, lobular_carcinoma, carcinoma, squamous_cell_carcinoma",,,,
842,842,650,D,H,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 650-656, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,16:14038623-14038623, hg38,16:13944766-13944766","hg19,16:g.14038623G>C, hg38,16:g.13944766G>C",0.143,breast,"carcinoma, carcinoma, ER-PR-positive_carcinoma",,,,
843,843,651,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 650-656, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM",,,,,,,,,,,,,
844,844,652,T,,P,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 650-656, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,,,,,,,,,,,,
845,845,653,N,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 650-656, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,,,,,,,,,,,,
846,846,654,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 650-656, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,,,,,,,,,,,,
847,847,655,D,H,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 650-656, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,"cBioPortal,COSMIC",brca_igr_2015,Invasive Breast Carcinoma,"hg19,16:14038638-14038638, hg38,16:13944781-13944781","hg19,16:g.14038638G>C, hg38,16:g.13944781G>C",0.232,breast,"carcinoma, carcinoma, HER-positive_carcinoma",,,,
848,848,655,D,Y,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 650-656, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_met_2021, nsclc_ctdx_msk_2022","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14038638-14038638","hg19,16:g.14038638G>T",0.330,,,,,,
849,849,656,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 646-656, ELM|FHA phosphopeptide ligands (LIG_FHA_2), 650-656, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,,,,,,,,,,,,
850,850,657,V,,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,,,,,,,,,,,,
851,851,658,R,G,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,cBioPortal,"mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14038647-14038647","hg19,16:g.14038647A>G",0.423,,,,,,
852,852,658,R,K,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 650-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 651-658, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 652-658, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14038648-14038648","hg19,16:g.14038648G>A",0.148,,,,,,
853,853,659,G,D,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
854,854,659,G,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
855,855,660,T,I,P,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
856,856,661,A,S,,,,,,,,,,,,,"cBioPortal,COSMIC",egc_mskcc_2020,Esophagus/Stomach,"hg19,16:14038656-14038656, hg38,16:13944799-13944799","hg19,16:g.14038656G>T, hg38,16:g.13944799G>T",0.061,prostate,"carcinoma, adenocarcinoma",,,,
857,857,662,S,P,P,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from ERCC4_icope_sentieon_input.csv,Manual annotations from mutations_clinvar.csv","breast_msk_2018, dlbc_tcga, mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Breast, Cutaneous Melanoma, Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,16:14038659-14038659, hg38,16:13944802-13944802","hg19,16:g.14038659T>C, hg38,16:g.13944802T>C",0.015,"breast, prostate, soft_tissue, striated_muscle, paratestis","carcinoma, carcinoma, ductal_carcinoma, rhabdomyosarcoma, embryonal",0.0157430780624149,0.0585780722431038,,
858,858,663,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 663-667, ELM",,,,,,,,,,,,,
859,859,664,D,N,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 663-667, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",coad_caseccc_2015,Colon Adenocarcinoma,"hg19,16:14038665-14038665","hg19,16:g.14038665G>A",0.023,,,,,,
860,860,665,V,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 663-667, ELM",,,,,,,,,,,,,
861,861,666,S,F,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 663-667, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:14038672-14038672, hg38,16:13944815-13944815","hg19,16:g.14038672C>T, hg38,16:g.13944815C>T",0.091,skin,malignant_melanoma,,,,
862,862,667,T,A,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 663-667, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
863,863,667,T,N,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 663-667, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
864,864,668,D,,,,,,,,,,,,,,,,,,,,,,,,,
865,865,669,T,,P,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 669-671, ELM",,,,,,,,,,,,,
866,866,670,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 669-671, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, cellline_ccle_broad, msk_met_2021",Mixed Cancer Types,"hg19,16:14038684-14038684","hg19,16:g.14038684G>A",0.419,,,4.78140987839e-05,9.55474871011e-05,,
867,867,670,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 669-671, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, msk_impact_2017, msk_met_2021, paired_bladder_2022, ucec_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14038683-14038683, hg38,16:13944826-13944826","hg19,16:g.14038683C>T, hg38,16:g.13944826C>T",0.469,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",3.984000255e-06,,,
868,868,671,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 669-671, ELM",,,,,,,,,,,,,
869,869,672,A,S,,,,,,,,,,,,,cBioPortal,"difg_glass_2019, pancan_pcawg_2020","Diffuse Glioma, Mixed Cancer Types","hg19,16:14038689-14038689","hg19,16:g.14038689G>T",0.315,,,,,,
870,870,672,A,V,,,,,,,,,,,,,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,16:14038690-14038690","hg19,16:g.14038690C>T",0.342,,,,,,
871,871,673,G,C,,,,,,,,,,,,,cBioPortal,"msk_met_2021, nsclc_ctdx_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14038692-14038692","hg19,16:g.14038692G>T",0.527,,,,,,
872,872,673,G,S,,,,,,,,,,,,,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13944835-13944835","hg38,16:g.13944835G>A",0.501,urinary_tract,"carcinoma, transitional_cell_carcinoma",3.9869864761e-06,,,
873,873,674,G,V,,,,,,,,,,,,,cBioPortal,"luad_mskcc_2023_met_organotropism, lung_msk_mind_2020, msk_met_2021","Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14041474-14041474","hg19,16:g.14041474G>T",0.625,,,,,,
874,874,675,Q,H,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041478-14041478","hg19,16:g.14041478G>T",0.233,,,,,,
875,875,676,E,Q,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
876,876,677,Q,,,,,,,,,,,,,,,,,,,,,,,,,
877,877,678,N,S,,,,,,,,,,,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,16:14041486-14041486, hg38,16:13947629-13947629","hg19,16:g.14041486A>G, hg38,16:g.13947629A>G",0.046,thyroid,"carcinoma, medullary_carcinoma",,,,
878,878,679,G,C,,,,,,,,,,,,,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:14041488-14041488, hg38,16:13947631-13947631","hg19,16:g.14041488G>T, hg38,16:g.13947631G>T",0.113,endometrium,"carcinoma, endometrioid_carcinoma",,,,
879,879,680,T,,,,,,,,,,,,,,,,,,,,,,,,,
880,880,681,Q,,,,,,,,,,,,,,,,,,,,,,,,,
881,881,682,Q,,,,,,,,,,,,,,,,,,,,,,,,,
882,882,683,S,N,,,,,,,,,,,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14041501-14041501","hg19,16:g.14041501G>A",0.082,,,,,,
883,883,684,I,T,,,,,,,,,,,,,"cBioPortal,COSMIC","hcc_mskimpact_2018, msk_impact_2017","Hepatocellular Carcinoma, Mixed Cancer Types","hg19,16:14041504-14041504, hg38,16:13947647-13947647","hg19,16:g.14041504T>C, hg38,16:g.13947647T>C",0.551,liver,"carcinoma, hepatocellular_carcinoma",,,,
884,884,685,V,,,,,,,,,,,,,,,,,,,,,,,,,
885,885,686,V,L,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041509-14041509","hg19,16:g.14041509G>T",0.549,,,,,,
886,886,687,D,H,,,,,,,,,,,,,"cBioPortal,COSMIC","blca_nmibc_2017, msk_impact_2017, msk_met_2021, paired_bladder_2022","Bladder Urothelial Carcinoma, Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14041512-14041512, hg38,16:13947655-13947655","hg19,16:g.14041512G>C, hg38,16:g.13947655G>C",0.910,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,
887,887,687,D,N,,,,,,,,,,,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,16:14041512-14041512","hg19,16:g.14041512G>A",0.849,,,,,,
888,888,688,M,L,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
889,889,689,R,C,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","egc_msk_tp53_ccr_2022, msk_access_2021, msk_impact_2017, msk_met_2021, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,16:14041518-14041518, hg38,16:13947661-13947661","hg19,16:g.14041518C>T, hg38,16:g.13947661C>T",0.629,"pancreas, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",3.9771868562e-06,,,
890,890,689,R,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
891,891,690,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC","hnc_mskcc_2016, msk_impact_2017","Head and Neck, Mixed Cancer Types","hg19,16:14041521-14041521, hg38,16:13947664-13947664","hg19,16:g.14041521G>A, hg38,16:g.13947664G>A",0.716,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma",,,,
892,892,691,F,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM",,,,,,,,,,,,,
893,893,692,R,Q,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
894,894,693,S,I,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
895,895,694,E,Q,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 694-699, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,16:14041533-14041533, hg38,16:13947676-13947676","hg19,16:g.14041533G>C, hg38,16:g.13947676G>C",0.239,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,
896,896,695,L,F,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 694-699, ELM",,"cBioPortal,COSMIC",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,16:14041536-14041536, hg38,16:13947679-13947679","hg19,16:g.14041536C>T, hg38,16:g.13947679C>T",0.524,breast,carcinoma,,,,
897,897,695,L,P,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 694-699, ELM",,"cBioPortal,COSMIC",stad_tcga_pub,Stomach Adenocarcinoma,"hg19,16:14041537-14041537, hg38,16:13947680-13947680","hg19,16:g.14041537T>C, hg38,16:g.13947680T>C",0.797,stomach,"carcinoma, adenocarcinoma",,,,
898,898,696,P,L,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 694-699, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041539-14041540, hg38,16:13947682-13947683","hg19,16:g.14041539_14041540delinsTT, hg38,16:g.13947682_13947683delinsTT",,skin,malignant_melanoma,,,,
899,899,696,P,S,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 694-699, ELM",,"cBioPortal,COSMIC","mel_ucla_2016, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Melanoma","hg19,16:14041539-14041539, hg38,16:13947682-13947682","hg19,16:g.14041539C>T, hg38,16:g.13947682C>T",0.543,skin,malignant_melanoma,,,,
900,900,697,S,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 694-699, ELM",,,,,,,,,,,,,
901,901,698,L,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 694-699, ELM",,,,,,,,,,,,,
902,902,699,I,,,,,,,,,,,,"APCC-binding Destruction motifs (DEG_APCC_DBOX_1), 691-699, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 694-699, ELM",,,,,,,,,,,,,
903,903,700,H,Y,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,COSMIC,,,"hg38,16:13947694-13947694","hg38,16:g.13947694C>T",0.285,"skin, scalp",malignant_melanoma,,,,
904,904,701,R,C,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 701-703, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","crc_apc_impact_2020, crc_msk_2017, mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041554-14041554, hg38,16:13947697-13947697","hg19,16:g.14041554C>T, hg38,16:g.13947697C>T",0.442,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",,3.18511912346e-05,,
905,905,701,R,G,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 701-703, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041554-14041554, hg38,16:13947697-13947697","hg19,16:g.14041554C>G, hg38,16:g.13947697C>G",0.284,skin,malignant_melanoma,3.9769654163e-06,,,
906,906,701,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 701-703, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:14041555-14041555, hg38,16:13947698-13947698","hg19,16:g.14041555G>A, hg38,16:g.13947698G>A",0.357,large_intestine,"carcinoma, adenocarcinoma",7.9541206322e-06,3.18532203606e-05,,
907,907,702,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 701-703, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
908,908,702,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 701-703, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","msk_met_2021, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14041557-14041557, hg38,16:13947700-13947700","hg19,16:g.14041557C>T, hg38,16:g.13947700C>T",0.500,endometrium,"carcinoma, endometrioid_carcinoma",3.9770919504e-06,,,
909,909,703,G,D,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 701-703, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,cBioPortal,"difg_glass_2019, pancan_pcawg_2020","Diffuse Glioma, Mixed Cancer Types","hg19,16:14041561-14041561","hg19,16:g.14041561G>A",0.616,,,,,,
910,910,703,G,V,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 701-703, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14041561-14041561","hg19,16:g.14041561G>T",0.786,,,3.9769654163e-06,,,
911,911,704,I,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,,,,,,,,,,,,
912,912,705,D,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
913,913,706,I,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM",,"cBioPortal,COSMIC,Manual annotations from ERCC4_icope_sentieon_input.csv,Manual annotations from mutations_clinvar.csv","acc_2019, blca_bcan_hcrn_2022, lymphoma_cellline_msk_2020","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Lymphoid","hg19,16:14041570-14041570, hg38,16:13947713-13947713","hg19,16:g.14041570T>C, hg38,16:g.13947713T>C",0.609,"lung, prostate","carcinoma, carcinoma, adenocarcinoma",0.0014675235837801,0.000955353162219,,
914,914,707,E,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM",,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_met_2021, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14041572-14041572","hg19,16:g.14041572G>A",0.295,,,,,,
915,915,707,E,Q,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM",,"cBioPortal,COSMIC","lusc_cptac_2021, msk_met_2021, paired_bladder_2022, summit_2018","Bladder/Urinary Tract, Lung Squamous Cell Carcinoma, Mixed Cancer Types","hg19,16:14041572-14041572, hg19,16:14041572-14041573, hg38,16:13947715-13947715","hg19,16:g.14041572G>C, hg38,16:g.13947715G>C",0.191,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,,,
916,916,708,P,L,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
917,917,708,P,S,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM",,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,16:14041575-14041575","hg19,16:g.14041575C>T",0.603,,,7.9541839007e-06,,,
918,918,709,V,L,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,COSMIC,,,"hg38,16:13947721-13947721","hg38,16:g.13947721G>C",0.141,liver,"other, neoplasm",,,,
919,919,709,V,M,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","coadread_dfci_2016, hcc_mskimpact_2018, nsclc_tcga_broad_2016","Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer","hg19,16:14041578-14041578, hg38,16:13947721-13947721","hg19,16:g.14041578G>A, hg38,16:g.13947721G>A",0.283,large_intestine,"carcinoma, adenocarcinoma",3.18162294586e-05,3.18511912346e-05,,
920,920,710,T,N,P,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
921,921,711,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_DCC_7), 701-711, ELM|MAPK docking motifs (DOC_MAPK_DCC_7), 702-711, ELM|MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,,,,,,,,,,,,
922,922,712,E,D,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,cBioPortal,sarcoma_mskcc_2022,Soft Tissue,"hg19,16:14041589-14041589","hg19,16:g.14041589G>C",0.240,,,,,,
923,923,712,E,K,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 707-712, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,cBioPortal,"msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Mixed Cancer Types","hg19,16:14041587-14041587","hg19,16:g.14041587G>A",0.201,,,,,,
924,924,713,V,A,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_HePTP_8), 698-713, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,cBioPortal,mixed_msk_tcga_2021,Mixed Cancer Types,"hg19,16:14041591-14041591","hg19,16:g.14041591T>C",0.607,,,3.9768072601e-06,,,
925,925,714,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 708-714, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,,,,,,,,,,,,
926,926,715,D,Y,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_par_1), 709-715, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
927,927,716,Y,C,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 716-719, ELM|TRFH domain docking motifs (LIG_TRFH_1), 716-720, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14041600-14041600, hg38,16:13947743-13947743","hg19,16:g.14041600A>G, hg38,16:g.13947743A>G",0.778,endometrium,"carcinoma, endometrioid_carcinoma",,,,
928,928,717,I,T,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM|WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 716-719, ELM|TRFH domain docking motifs (LIG_TRFH_1), 716-720, ELM",,cBioPortal,"coadread_tcga_pan_can_atlas_2018, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14041603-14041603","hg19,16:g.14041603T>C",0.527,,,,,,
929,929,718,L,H,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM|WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 716-719, ELM|TRFH domain docking motifs (LIG_TRFH_1), 716-720, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041606-14041606","hg19,16:g.14041606T>A",0.714,,,,,,
930,930,719,T,I,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM|WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 716-719, ELM|TRFH domain docking motifs (LIG_TRFH_1), 716-720, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:14041609-14041609","hg19,16:g.14041609C>T",0.318,,,3.9770286823e-06,,,
931,931,719,T,N,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM|WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 716-719, ELM|TRFH domain docking motifs (LIG_TRFH_1), 716-720, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
932,932,720,P,L,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM|WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM|TRFH domain docking motifs (LIG_TRFH_1), 716-720, ELM",,"cBioPortal,COSMIC","bcc_unige_2016, mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Basal Cell Carcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041612-14041612, hg38,16:13947755-13947755","hg19,16:g.14041612C>T, hg38,16:g.13947755C>T",0.455,skin,"carcinoma, basal_cell_carcinoma",,,,
933,933,720,P,Q,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM|WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM|TRFH domain docking motifs (LIG_TRFH_1), 716-720, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:14041612-14041612, hg38,16:13947755-13947755","hg19,16:g.14041612C>A, hg38,16:g.13947755C>A",0.418,skin,malignant_melanoma,,,,
934,934,721,E,K,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM|WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM",,"cBioPortal,COSMIC","skcm_broad, skcm_broad_dfarber",Cutaneous Melanoma,"hg19,16:14041614-14041614, hg38,16:13947757-13947757","hg19,16:g.14041614G>A, hg38,16:g.13947757G>A",0.156,"skin, trunk",malignant_melanoma,,,,
935,935,721,E,Q,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM|WW domain ligands (DOC_WW_Pin1_4), 716-721, ELM",,COSMIC,,,"hg38,16:13947757-13947757","hg38,16:g.13947757G>C",0.176,breast,"carcinoma, HER-positive_carcinoma",,,,
936,936,722,M,V,,,,,,,,,,,"Cks1 ligand (DOC_CKS1_1), 717-722, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
937,937,723,C,Y,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041621-14041621","hg19,16:g.14041621G>A",0.618,,,,,,
938,938,724,V,L,,,,,,,,,,,,,cBioPortal,"coadread_tcga, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,16:14041623-14041623","hg19,16:g.14041623G>T",0.347,,,,,,
939,939,724,V,M,,,,,,,,,,,,,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14041623-14041623","hg19,16:g.14041623G>A",0.428,,,,,,
940,940,725,E,A,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 725-727, ELM",,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,16:14041627-14041627","hg19,16:g.14041627A>C",0.814,,,,,,
941,941,725,E,K,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 725-727, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,16:14041626-14041626, hg38,16:13947769-13947769","hg19,16:g.14041626G>A, hg38,16:g.13947769G>A",0.734,breast,"carcinoma, lobular_carcinoma",,,,
942,942,725,E,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 725-727, ELM",,cBioPortal,"egc_msk_2017, egc_msk_tp53_ccr_2022, egc_mskcc_2020, msk_met_2021, tmb_mskcc_2018","Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types","hg19,16:14041626-14041626","hg19,16:g.14041626G>C",0.632,,,,,,
943,943,726,R,C,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 725-727, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","crc_msk_2017, lihc_tcga, lihc_tcga_pan_can_atlas_2018, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Hepatocellular Carcinoma, Mixed Cancer Types","hg19,16:14041629-14041629, hg38,16:13947772-13947772","hg19,16:g.14041629C>T, hg38,16:g.13947772C>T",0.774,"large_intestine, colon, descending, liver, prostate","carcinoma, carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma",1.98895730902e-05,,,
944,944,726,R,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 725-727, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14041630-14041630","hg19,16:g.14041630G>A",0.842,,,2.38655890027e-05,,,
945,945,726,R,P,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 725-727, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016, pptc_2019","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14041630-14041630, hg38,16:13947773-13947773","hg19,16:g.14041630G>C, hg38,16:g.13947773G>C",0.838,lung,"carcinoma, adenocarcinoma",3.9775981671e-06,,,
946,946,727,K,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 725-727, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,,,,,,,,,,,,
947,947,728,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,,,,,,,,,,,,
948,948,729,I,T,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
949,949,730,S,G,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,cBioPortal,"pancan_pcawg_2020, stad_oncosg_2018","Mixed Cancer Types, Stomach Adenocarcinoma","hg19,16:14041641-14041641","hg19,16:g.14041641A>G",0.155,,,,,,
950,950,731,D,Y,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,COSMIC,,,"hg38,16:13947787-13947787","hg38,16:g.13947787G>T",0.852,liver,"other, neoplasm",,,,
951,951,732,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,,,,,,,,,,,,
952,952,733,I,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,,,,,,,,,,,,
953,953,734,G,S,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14041653-14041653, hg38,16:13947796-13947796","hg19,16:g.14041653G>A, hg38,16:g.13947796G>A",0.317,"large_intestine, caecum","carcinoma, adenocarcinoma",1.98914721281e-05,,,
954,954,735,S,Y,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041657-14041657","hg19,16:g.14041657C>A",0.623,,,,,,
955,955,736,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 726-736, ELM",,,,,,,,,,,,,
956,956,737,N,,,,,,,,,,,,,,,,,,,,,,,,,
957,957,738,N,D,,,,,,,,,,,"Integrin RGD-type binding sites (LIG_Integrin_isoDGR_2), 738-740, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
958,958,738,N,K,,,,,,,,,,,"Integrin RGD-type binding sites (LIG_Integrin_isoDGR_2), 738-740, ELM",,cBioPortal,nsclc_tcga_broad_2016,Non-Small Cell Lung Cancer,"hg19,16:14041667-14041667","hg19,16:g.14041667C>A",0.107,,,,,,
959,959,739,G,D,,,,,,,,,,,"Integrin RGD-type binding sites (LIG_Integrin_isoDGR_2), 738-740, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,16:14041669-14041669","hg19,16:g.14041669G>A",0.694,,,,,,
960,960,739,G,S,,,,,,,,,,,"Integrin RGD-type binding sites (LIG_Integrin_isoDGR_2), 738-740, ELM",,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,16:14041668-14041668","hg19,16:g.14041668G>A",0.597,,,7.9573486114e-06,,,
961,961,740,R,C,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM|Integrin RGD-type binding sites (LIG_Integrin_isoDGR_2), 738-740, ELM",,"cBioPortal,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, cscc_ucsf_2021, egc_msk_tp53_ccr_2022","Cutaneous Squamous Cell Carcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types","hg19,16:14041671-14041671","hg19,16:g.14041671C>T",0.595,,,2.78460669419e-05,6.36902108146e-05,,
962,962,740,R,H,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM|Integrin RGD-type binding sites (LIG_Integrin_isoDGR_2), 738-740, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13947815-13947815","hg38,16:g.13947815G>A",0.757,"central_nervous_system, brain, lung","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",3.18255957354e-05,,,
963,963,741,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM",,,,,,,,,,,,,
964,964,742,Y,,P,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 742-746, ELM",,,,,,,,,,,,,
965,965,743,S,R,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 742-746, ELM",,cBioPortal,lung_msk_pdx,Lung,"hg19,16:14041682-14041682","hg19,16:g.14041682C>G",0.092,,,3.9779779143e-06,,,
966,966,744,Q,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 742-746, ELM",,,,,,,,,,,,,
967,967,745,C,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 742-746, ELM",,,,,,,,,,,,,
968,968,746,I,M,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 742-746, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
969,969,746,I,V,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 742-746, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
970,970,747,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM",,,,,,,,,,,,,
971,971,748,M,V,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 740-748, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041695-14041695, hg38,16:13947838-13947838","hg19,16:g.14041695A>G, hg38,16:g.13947838A>G",0.616,"urinary_tract, bladder",carcinoma,,,,
972,972,749,S,,,,,,,,,,,,,,,,,,,,,,,,,
973,973,750,R,C,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","egc_msk_2017, msk_impact_2017, tmb_mskcc_2018","Esophagogastric Adenocarcinoma, Mixed Cancer Types","hg19,16:14041701-14041701, hg38,16:13947844-13947844","hg19,16:g.14041701C>T, hg38,16:g.13947844C>T",0.589,stomach,"carcinoma, adenocarcinoma",5.56890324428e-05,3.1849162367e-05,,
974,974,750,R,H,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","cesc_tcga_pan_can_atlas_2018, coad_silu_2022","Cervical Squamous Cell Carcinoma, Colon Adenocarcinoma","hg19,16:14041702-14041702, hg38,16:13947845-13947845","hg19,16:g.14041702G>A, hg38,16:g.13947845G>A",0.484,cervix,"carcinoma, squamous_cell_carcinoma",3.9778196775e-06,,,
975,975,750,R,S,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM",,COSMIC,,,"hg38,16:13947844-13947844","hg38,16:g.13947844C>A",0.548,"skin, mucosal, anorectal",malignant_melanoma,,,,
976,976,751,Y,C,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
977,977,751,Y,H,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM",,"cBioPortal,COSMIC","lihc_tcga_pan_can_atlas_2018, msk_met_2021, paired_bladder_2022","Bladder/Urinary Tract, Hepatocellular Carcinoma, Mixed Cancer Types","hg19,16:14041704-14041704, hg38,16:13947847-13947847","hg19,16:g.14041704T>C, hg38,16:g.13947847T>C",0.114,liver,"carcinoma, hepatocellular_carcinoma",,,,
978,978,752,Y,,P,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 752-756, ELM|eIF4E binding motif (LIG_eIF4E_1), 752-758, ELM",,,,,,,,,,,,,
979,979,753,K,,,,Ubq,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 753-755, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 752-756, ELM|eIF4E binding motif (LIG_eIF4E_1), 752-758, ELM",,,,,,,,,,,,,
980,980,754,R,C,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 753-755, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 754-758, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 752-756, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 754-760, ELM|eIF4E binding motif (LIG_eIF4E_1), 752-758, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","rectal_msk_2022, ucec_tcga_pan_can_atlas_2018","Bowel, Endometrial Carcinoma","hg19,16:14041713-14041713, hg38,16:13947856-13947856","hg19,16:g.14041713C>T, hg38,16:g.13947856C>T",0.183,endometrium,"carcinoma, endometrioid_carcinoma",7.9554494829e-06,,,
981,981,754,R,L,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 753-755, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 754-758, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 752-756, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 754-760, ELM|eIF4E binding motif (LIG_eIF4E_1), 752-758, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14041714-14041714, hg38,16:13947857-13947857","hg19,16:g.14041714G>T, hg38,16:g.13947857G>T",0.256,"lung, right_lower_lobe","carcinoma, adenocarcinoma",,,,
982,982,755,P,L,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 753-755, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 754-758, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 752-756, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 754-760, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 755-760, ELM|eIF4E binding motif (LIG_eIF4E_1), 752-758, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14041717-14041717, hg38,16:13947860-13947860","hg19,16:g.14041717C>T, hg38,16:g.13947860C>T",0.641,lung,"carcinoma, large_cell_neuroendocrine_carcinoma",,,,
983,983,756,V,M,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 754-758, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 752-756, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 754-760, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 755-760, ELM|eIF4E binding motif (LIG_eIF4E_1), 752-758, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","msk_met_2021, nsclc_ctdx_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14041719-14041719, hg38,16:13947862-13947862","hg19,16:g.14041719G>A, hg38,16:g.13947862G>A",0.078,prostate,carcinoma,0.0001312638722047,,,
984,984,757,L,F,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 754-758, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 754-760, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 755-760, ELM|eIF4E binding motif (LIG_eIF4E_1), 752-758, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,16:14041722-14041722, hg38,16:13947865-13947865","hg19,16:g.14041722C>T, hg38,16:g.13947865C>T",0.449,skin,"carcinoma, Merkel_cell_carcinoma",,,,
985,985,758,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 754-758, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Clathrin box (LIG_Clathr_ClatBox_1), 758-762, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 754-760, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 755-760, ELM|eIF4E binding motif (LIG_eIF4E_1), 752-758, ELM",,,,,,,,,,,,,
986,986,759,I,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 750-759, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 750-759, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Clathrin box (LIG_Clathr_ClatBox_1), 758-762, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 754-760, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 755-760, ELM",,COSMIC,,,"hg38,16:13947871-13947871","hg38,16:g.13947871A>G",0.287,large_intestine,"carcinoma, adenocarcinoma",,,,
987,987,760,E,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Clathrin box (LIG_Clathr_ClatBox_1), 758-762, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 754-760, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 755-760, ELM",,,,,,,,,,,,,
988,988,761,F,L,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 753-761, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 754-761, ELM|MAPK docking motifs (DOC_MAPK_gen_1), 753-761, ELM|Clathrin box (LIG_Clathr_ClatBox_1), 758-762, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
989,989,762,D,E,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 758-762, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
990,990,762,D,G,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 758-762, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,16:14041738-14041738, hg38,16:13947881-13947881","hg19,16:g.14041738A>G, hg38,16:g.13947881A>G",0.808,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
991,991,762,D,H,,,,,,,,,,,"Clathrin box (LIG_Clathr_ClatBox_1), 758-762, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14041737-14041737, hg38,16:13947880-13947880","hg19,16:g.14041737G>C, hg38,16:g.13947880G>C",0.674,skin,"carcinoma, squamous_cell_carcinoma",,,,
992,992,763,P,L,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 763-767, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,"COSMIC,Manual annotations from mutations_clinvar.csv",,,"hg38,16:13947884-13947884","hg38,16:g.13947884C>T",0.229,ovary,"sex_cord-stromal_tumour, granulosa_cell_tumour",,6.36902108146e-05,,
993,993,764,S,G,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 763-767, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
994,994,765,K,N,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 763-767, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
995,995,766,P,H,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 763-767, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,"cBioPortal,COSMIC","luad_mskcc_2023_met_organotropism, lung_msk_2017, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14041750-14041750, hg38,16:13947893-13947893","hg19,16:g.14041750C>A, hg38,16:g.13947893C>A",0.474,lung,"carcinoma, adenocarcinoma",,,,
996,996,766,P,S,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 763-767, ELM|SH3 ligand (LIG_SH3_3), 760-766, ELM",,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,16:14041749-14041749","hg19,16:g.14041749C>T",0.177,,,,,,
997,997,767,F,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 763-767, ELM",,,,,,,,,,,,,
998,998,768,S,C,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
999,999,768,S,F,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:14041756-14041756, hg38,16:13947899-13947899","hg19,16:g.14041756C>T, hg38,16:g.13947899C>T",0.332,skin,malignant_melanoma,,,,
1000,1000,769,L,V,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_broad, msk_met_2021, nsclc_tcga_broad_2016, paired_bladder_2022","Bladder/Urinary Tract, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14041758-14041758, hg38,16:13947901-13947901","hg19,16:g.14041758C>G, hg38,16:g.13947901C>G",0.242,lung,"carcinoma, adenocarcinoma",,,,
1001,1001,770,T,I,,,,,,,,,,,,,COSMIC,,,"hg38,16:13947905-13947905","hg38,16:g.13947905C>T",0.037,lung,"carcinoma, adenocarcinoma",,,,
1002,1002,770,T,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1003,1003,771,S,A,,,,,,,,,,,,,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,16:14041764-14041764","hg19,16:g.14041764T>G",0.059,,,,,,
1004,1004,771,S,F,,,,,,,,,,,,,"cBioPortal,COSMIC","msk_met_2021, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041765-14041765, hg38,16:13947908-13947908","hg19,16:g.14041765C>T, hg38,16:g.13947908C>T",0.195,skin,malignant_melanoma,,,,
1005,1005,772,R,Q,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 772-776, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041768-14041768","hg19,16:g.14041768G>A",0.115,,,3.9778196775e-06,,,
1006,1006,773,G,R,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 772-776, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1007,1007,773,G,S,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 772-776, ELM",,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017, odg_msk_2017, tmb_mskcc_2018","Diffuse Glioma, Mixed Cancer Types, Oligodendroglioma","hg19,16:14041770-14041770, hg38,16:13947913-13947913","hg19,16:g.14041770G>A, hg38,16:g.13947913G>A",0.059,"central_nervous_system, brain","glioma, oligodendroglioma_Grade_III, anaplastic",,,,
1008,1008,774,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 772-776, ELM",,,,,,,,,,,,,
1009,1009,775,L,F,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 772-776, ELM",,COSMIC,,,"hg38,16:13947921-13947921","hg38,16:g.13947921G>T",0.017,liver,"other, neoplasm",,,,
1010,1010,775,L,S,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 772-776, ELM",,COSMIC,,,"hg38,16:13947920-13947920","hg38,16:g.13947920T>C",0.112,,malignant_melanoma,,,,
1011,1011,775,L,V,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 772-776, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1012,1012,776,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 772-776, ELM",,,,,,,,,,,,,
1013,1013,777,Q,,,,,,,,,,,,,,,,,,,,,,,,,
1014,1014,778,E,D,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1015,1015,779,I,,,,,,,,,,,,,,,,,,,,,,,,,
1016,1016,780,S,C,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1017,1017,780,S,Y,,,,,,,,,,,,,cBioPortal,"msk_access_2021, msk_met_2021",Mixed Cancer Types,"hg19,16:14041792-14041792","hg19,16:g.14041792C>A",0.407,,,,,,
1018,1018,781,S,,,,,,,,,,,,,,,,,,,,,,,,,
1019,1019,782,N,S,,,,,,,,,,,,,cBioPortal,"luad_mskcc_2023_met_organotropism, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14041798-14041798","hg19,16:g.14041798A>G",0.097,,,7.9562723273e-06,,,
1020,1020,783,D,G,,,,,,,,,,,,,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,16:14041801-14041801","hg19,16:g.14041801A>G",0.491,,,7.9558925318e-06,,,
1021,1021,783,D,Y,,,,,,,,,,,,,cBioPortal,"lung_msk_pdx, lung_pdx_msk_2021, msk_met_2021, tmb_mskcc_2018","Lung, Mixed Cancer Types","hg19,16:14041800-14041800","hg19,16:g.14041800G>T",0.639,,,,,,
1022,1022,784,I,S,,,,,,,,,,,,,COSMIC,,,"hg38,16:13947947-13947947","hg38,16:g.13947947T>G",0.346,lung,"carcinoma, non_small_cell_carcinoma",,,,
1023,1023,785,S,G,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,16:14041806-14041806","hg19,16:g.14041806A>G",0.125,,,,,,
1024,1024,785,S,N,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,16:14041807-14041807, hg38,16:13947950-13947950","hg19,16:g.14041807G>A, hg38,16:g.13947950G>A",0.054,thyroid,"carcinoma, anaplastic_carcinoma",,,,
1025,1025,786,S,F,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1026,1026,786,S,T,,,,,,,,,,,"SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,16:14041809-14041809","hg19,16:g.14041809T>A",0.193,,,,,,
1027,1027,787,K,E,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:14041812-14041812","hg19,16:g.14041812A>G",0.411,,,,,,
1028,1028,788,L,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,cBioPortal,"lung_msk_mind_2020, nsclc_pd1_msk_2018, tmb_mskcc_2018","Lung, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14041815-14041815","hg19,16:g.14041815C>G",0.212,,,,,,
1029,1029,789,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,,,,,,,,,,,,
1030,1030,790,L,F,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,cBioPortal,lung_nci_2022,Lung Adenocarcinoma,"hg19,16:14041821-14041821","hg19,16:g.14041821C>T",0.285,,,,,,
1031,1031,790,L,P,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1032,1032,790,L,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041821-14041821","hg19,16:g.14041821C>G",0.257,,,,,,
1033,1033,791,L,F,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041824-14041824","hg19,16:g.14041824C>T",0.547,,,,,,
1034,1034,792,T,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 785-792, ELM|SUMO interaction site (LIG_SUMO_SIM_anti_2), 786-792, ELM",,,,,,,,,,,,,
1035,1035,793,L,I,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:14041830-14041830","hg19,16:g.14041830C>A",0.174,,,,,,
1036,1036,793,L,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1037,1037,794,H,L,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041834-14041835","hg19,16:g.14041834_14041835delinsTT",,,,,,,
1038,1038,795,F,C,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM",,COSMIC,,,"hg38,16:13947980-13947980","hg38,16:g.13947980T>G",0.597,lung,"carcinoma, adenocarcinoma",,,,
1039,1039,795,F,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 787-795, ELM",,"cBioPortal,COSMIC",esca_broad,Esophageal Adenocarcinoma,"hg19,16:14041836-14041836, hg38,16:13947979-13947979","hg19,16:g.14041836T>G, hg38,16:g.13947979T>G",0.566,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,,,
1040,1040,796,P,L,,,,,,,,,,,"di Arginine retention/retrieving signal (TRG_ER_diArg_1), 796-799, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,16:14041840-14041840, hg38,16:13947983-13947983","hg19,16:g.14041840C>T, hg38,16:g.13947983C>T",0.601,"skin, upper_back, stomach","carcinoma, malignant_melanoma",,,,
1041,1041,797,R,I,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 796-799, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 797-800, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:14041843-14041843, hg38,16:13947986-13947986","hg19,16:g.14041843G>T, hg38,16:g.13947986G>T",0.173,endometrium,"carcinoma, endometrioid_carcinoma",,,,
1042,1042,797,R,K,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 796-799, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 797-800, ELM",,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017, tmb_mskcc_2018","Diffuse Glioma, Mixed Cancer Types","hg19,16:14041843-14041843, hg38,16:13947986-13947986","hg19,16:g.14041843G>A, hg38,16:g.13947986G>A",0.111,"central_nervous_system, brain","glioma, oligodendroglioma_Grade_III, anaplastic",,3.1849162367e-05,,
1043,1043,798,L,V,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 796-799, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 797-800, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,16:14041845-14041845, hg38,16:13947988-13947988","hg19,16:g.14041845C>G, hg38,16:g.13947988C>G",0.286,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",1.59164703635e-05,6.36983247341e-05,,
1044,1044,799,R,Q,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 796-799, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 797-800, ELM",,"cBioPortal,COSMIC","hnc_mskcc_2016, msk_impact_2017, msk_met_2021, rectal_msk_2022","Bowel, Head and Neck, Mixed Cancer Types","hg19,16:14041849-14041849, hg38,16:13947992-13947992","hg19,16:g.14041849G>A, hg38,16:g.13947992G>A",0.472,skin,"carcinoma, squamous_cell_carcinoma, malignant_melanoma",3.9797510268e-06,6.37226789014e-05,,
1045,1045,799,R,W,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 796-799, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 797-800, ELM",,"cBioPortal,COSMIC,Manual annotations from ERCC4_icope_sentieon_input.csv,Manual annotations from mutations_clinvar.csv","acc_2019, blca_bcan_hcrn_2022, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Adenoid Cystic Carcinoma, Bladder Urothelial Carcinoma, Endometrial Carcinoma","hg19,16:14041848-14041848, hg38,16:13947991-13947991","hg19,16:g.14041848C>T, hg38,16:g.13947991C>T",0.510,"cervix, endometrium, large_intestine, prostate, thyroid","carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, papillary_carcinoma, carcinoma, squamous_cell_carcinoma",0.0004814732284968,0.0001274291175534,,
1046,1046,800,I,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 797-800, ELM",,,,,,,,,,,,,
1047,1047,801,L,I,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, msk_met_2021, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,16:14041854-14041854, hg38,16:13947997-13947997","hg19,16:g.14041854C>A, hg38,16:g.13947997C>A",0.164,"breast, endometrium","carcinoma, carcinoma, endometrioid_carcinoma",,,,
1048,1048,802,W,,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM|WW domain ligands (DOC_WW_Pin1_4), 802-807, ELM",,,,,,,,,,,,,
1049,1049,803,C,F,,,,,,,,,,,"PP1-docking motif RVXF (DOC_PP1_RVXF_1), 797-803, ELM|WW domain ligands (DOC_WW_Pin1_4), 802-807, ELM",,cBioPortal,"lihc_amc_prv, luad_mskcc_2023_met_organotropism, msk_met_2021, nsclc_ctdx_msk_2022","Hepatocellular Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:14041861-14041861","hg19,16:g.14041861G>T",0.586,,,,,,
1050,1050,804,P,H,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 802-807, ELM",,"cBioPortal,COSMIC","crc_apc_impact_2020, crc_msk_2017, msk_impact_2017","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14041864-14041864, hg38,16:13948007-13948007","hg19,16:g.14041864C>A, hg38,16:g.13948007C>A",0.336,"endometrium, large_intestine, caecum","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,,,
1051,1051,804,P,S,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 802-807, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:14041863-14041863, hg38,16:13948006-13948006","hg19,16:g.14041863C>T, hg38,16:g.13948006C>T",0.239,skin,malignant_melanoma,,,,
1052,1052,805,S,F,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 802-807, ELM",,COSMIC,,,"hg38,16:13948010-13948010","hg38,16:g.13948010C>T",0.509,lung,"carcinoma, acinar_adenocarcinoma",,,,
1053,1053,806,P,S,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 802-807, ELM",,"cBioPortal,COSMIC",hcc_inserm_fr_2015,Hepatocellular Carcinoma,"hg19,16:14041869-14041869, hg38,16:13948012-13948012","hg19,16:g.14041869C>T, hg38,16:g.13948012C>T",0.435,liver,"carcinoma, hepatocellular_carcinoma",,,,
1054,1054,807,H,D,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 802-807, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 807-813, ELM",,COSMIC,,,"hg38,16:13948015-13948015","hg38,16:g.13948015C>G",0.263,"urinary_tract, bladder","carcinoma, small_cell_carcinoma",,,,
1055,1055,807,H,R,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 802-807, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 807-813, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041873-14041873","hg19,16:g.14041873A>G",0.289,,,,,,
1056,1056,808,A,G,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 807-813, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1057,1057,809,T,M,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 807-813, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, cfdna_msk_2019, esca_broad","Esophageal Adenocarcinoma, Mixed Cancer Types","hg19,16:14041879-14041879, hg38,16:13948022-13948022","hg19,16:g.14041879C>T, hg38,16:g.13948022C>T",0.478,"oesophagus, prostate","carcinoma, carcinoma, adenocarcinoma",7.9606425831e-06,,,
1058,1058,810,A,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 807-813, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, coadread_dfci_2016, msk_met_2021, rectal_msk_2022","Bowel, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14041882-14041882, hg38,16:13948025-13948025","hg19,16:g.14041882C>T, hg38,16:g.13948025C>T",0.344,large_intestine,"carcinoma, adenocarcinoma",,,,
1059,1059,811,E,D,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 807-813, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM",,cBioPortal,"hgsoc_msk_2021, msk_met_2021","High-Grade Serous Ovarian Cancer, Mixed Cancer Types","hg19,16:14041886-14041886","hg19,16:g.14041886G>C",0.099,,,,,,
1060,1060,812,L,F,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 807-813, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,cBioPortal,blca_bcan_hcrn_2022,Bladder Urothelial Carcinoma,"hg19,16:14041889-14041889","hg19,16:g.14041889G>T",0.282,,,,,,
1061,1061,813,F,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 807-813, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,,,,,,,,,,,,
1062,1062,814,E,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,,,,,,,,,,,,
1063,1063,815,E,V,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,"cBioPortal,COSMIC","kich_tcga, kich_tcga_pan_can_atlas_2018",Chromophobe Renal Cell Carcinoma,"hg19,16:14041897-14041897, hg38,16:13948040-13948040","hg19,16:g.14041897A>T, hg38,16:g.13948040A>T",0.261,kidney,"carcinoma, chromophobe_renal_cell_carcinoma",,,,
1064,1064,816,L,P,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041900-14041900","hg19,16:g.14041900T>C",0.656,,,,,,
1065,1065,817,K,Q,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1066,1066,818,Q,E,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1067,1067,819,S,G,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,16:14041908-14041908, hg38,16:13948051-13948051","hg19,16:g.14041908A>G, hg38,16:g.13948051A>G",0.219,liver,"carcinoma, hepatocellular_carcinoma",,,,
1068,1068,820,K,E,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, cellline_nci60",Mixed Cancer Types,"hg19,16:14041911-14041911, hg38,16:13948054-13948054","hg19,16:g.14041911A>G, hg38,16:g.13948054A>G",0.040,"large_intestine, large_intestine, colon","carcinoma, carcinoma, adenocarcinoma",,,,
1069,1069,820,K,R,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 812-820, ELM",,COSMIC,,,"hg38,16:13948055-13948055","hg38,16:g.13948055A>G",0.139,breast,"carcinoma, ductal_carcinoma",3.9800995025e-06,,,
1070,1070,821,P,S,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 811-821, ELM",,"cBioPortal,COSMIC","msk_met_2021, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14041914-14041914, hg38,16:13948057-13948057","hg19,16:g.14041914C>T, hg38,16:g.13948057C>T",0.119,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,,,
1071,1071,822,Q,,,,,,,,,,,,,,,,,,,,,,,,,
1072,1072,823,P,,,,,,,,,,,,,,,,,,,,,,,,,
1073,1073,824,D,N,,,,,,,,,,,,,"cBioPortal,COSMIC","hnc_mskcc_2016, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_impact_2017, msk_met_2021","Head and Neck, Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14041923-14041923, hg38,16:13948066-13948066","hg19,16:g.14041923G>A, hg38,16:g.13948066G>A",0.256,skin,"carcinoma, squamous_cell_carcinoma",,,,
1074,1074,825,A,G,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:14041927-14041927","hg19,16:g.14041927C>G",0.182,,,3.18458660085e-05,,,
1075,1075,825,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","brca_mapk_hp_msk_2021, msk_met_2021, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Endometrial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,16:14041927-14041927, hg38,16:13948070-13948070","hg19,16:g.14041927C>T, hg38,16:g.13948070C>T",0.055,endometrium,"carcinoma, endometrioid_carcinoma",3.9807332511e-06,3.18532203606e-05,,
1076,1076,826,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, msk_met_2021, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14041930-14041930, hg38,16:13948073-13948073","hg19,16:g.14041930C>T, hg38,16:g.13948073C>T",0.066,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",1.59212851661e-05,,,
1077,1077,827,T,A,,,,,,,,,,,,,"cBioPortal,COSMIC",esca_broad,Esophageal Adenocarcinoma,"hg19,16:14041932-14041932, hg38,16:13948075-13948075","hg19,16:g.14041932A>G, hg38,16:g.13948075A>G",0.090,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,,,
1078,1078,827,T,K,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1079,1079,827,T,S,,,,,,,,,,,,,COSMIC,,,"hg38,16:13948075-13948075","hg38,16:g.13948075A>T",0.161,lung,"carcinoma, adenocarcinoma",,,,
1080,1080,828,A,,,,,,,,,,,,,,,,,,,,,,,,,
1081,1081,829,L,M,,,,,,,,,,,,,cBioPortal,skcm_dfci_2015,Cutaneous Melanoma,"hg19,16:14041938-14041938","hg19,16:g.14041938C>A",0.071,,,,,,
1082,1082,830,A,T,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041941-14041941","hg19,16:g.14041941G>A",0.218,,,,,,
1083,1083,831,I,V,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1084,1084,832,T,I,,,,,,,,,,,,,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:14041948-14041948, hg38,16:13948091-13948091","hg19,16:g.14041948C>T, hg38,16:g.13948091C>T",0.271,endometrium,"carcinoma, endometrioid_carcinoma",,,,
1085,1085,833,A,T,,,,,,,,,,,,,COSMIC,,,"hg38,16:13948093-13948093","hg38,16:g.13948093G>A",0.180,liver,"carcinoma, hepatocellular_carcinoma",,,,
1086,1086,834,D,A,,,,,,,,,,,,,COSMIC,,,"hg38,16:13948097-13948097","hg38,16:g.13948097A>C",0.316,liver,"carcinoma, hepatocellular_carcinoma, other, neoplasm",,,,
1087,1087,834,D,Y,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1088,1088,835,S,Y,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1089,1089,836,E,K,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",nsclc_tcga_broad_2016,Non-Small Cell Lung Cancer,"hg19,16:14041959-14041959, hg38,16:13948102-13948102","hg19,16:g.14041959G>A, hg38,16:g.13948102G>A",0.257,lung,"carcinoma, adenocarcinoma",3.9789275994e-06,3.18390219052e-05,,
1090,1090,837,T,I,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14041963-14041963","hg19,16:g.14041963C>T",0.102,,,,,,
1091,1091,838,L,R,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041966-14041966","hg19,16:g.14041966T>G",0.159,,,,,,
1092,1092,839,P,L,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,16:14041969-14041969, hg38,16:13948112-13948112","hg19,16:g.14041969C>T, hg38,16:g.13948112C>T",0.159,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,,,
1093,1093,840,E,A,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1094,1094,840,E,K,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,"cBioPortal,COSMIC","gbm_tcga, gbm_tcga_pan_can_atlas_2018, gbm_tcga_pub2013, lgggbm_tcga_pub","Diffuse Glioma, Glioblastoma Multiforme","hg19,16:14041971-14041971, hg38,16:13948114-13948114","hg19,16:g.14041971G>A, hg38,16:g.13948114G>A",0.203,", central_nervous_system, brain, soft_tissue, fat","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, liposarcoma, pleomorphic, malignant_melanoma",1.98921052213e-05,,,
1095,1095,841,S,A,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041974-14041974","hg19,16:g.14041974T>G",0.093,,,,,,
1096,1096,841,S,L,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 835-841, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041975-14041975","hg19,16:g.14041975C>T",0.168,,,3.978167815e-06,3.1847133758e-05,,
1097,1097,842,E,K,,,,,,,,,,,,,cBioPortal,brca_cptac_2020,Invasive Breast Carcinoma,"hg19,16:14041977-14041977","hg19,16:g.14041977G>A",0.098,,,,,,
1098,1098,843,K,,,,Ubq,,,,,,,,,,,,,,,,,,,,,
1099,1099,844,Y,C,,,,,,,,,,,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,16:14041984-14041984, hg38,16:13948127-13948127","hg19,16:g.14041984A>G, hg38,16:g.13948127A>G",0.479,liver,carcinoma,,,,
1100,1100,845,N,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1101,1101,846,P,L,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14041990-14041990","hg19,16:g.14041990C>T",0.163,,,7.9553861942e-06,,,
1102,1102,846,P,S,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:14041989-14041989, hg38,16:13948132-13948132","hg19,16:g.14041989C>T, hg38,16:g.13948132C>T",0.206,skin,malignant_melanoma,,,,
1103,1103,847,G,C,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1104,1104,848,P,L,,,,,,,,,,,,,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_met_2021, pancan_pcawg_2020, skcm_tcga_pan_can_atlas_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041996-14041996, hg38,16:13948139-13948139","hg19,16:g.14041996C>T, hg38,16:g.13948139C>T",0.345,skin,malignant_melanoma,,,,
1105,1105,848,P,S,,,,,,,,,,,,,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_met_2021, skcm_broad, skcm_broad_dfarber","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14041995-14041995, hg38,16:13948138-13948138","hg19,16:g.14041995C>T, hg38,16:g.13948138C>T",0.168,skin,malignant_melanoma,,,,
1106,1106,849,Q,E,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",pptc_2019,Mixed Cancer Types,"hg19,16:14041998-14041998","hg19,16:g.14041998C>G",0.132,,,8.75050713166e-05,9.55474871011e-05,,
1107,1107,849,Q,L,,,,,,,,,,,,,"Manual annotations from ERCC4_icope_sentieon_input.csv,Manual annotations from mutations_clinvar.csv",,,,,,,,,,,
1108,1108,850,D,H,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:14042001-14042001, hg38,16:13948144-13948144","hg19,16:g.14042001G>C, hg38,16:g.13948144G>C",0.495,stomach,"carcinoma, adenocarcinoma",,,,
1109,1109,850,D,V,,,,,,,,,,,,,cBioPortal,luad_cptac_2020,Lung Adenocarcinoma,"hg19,16:14042002-14042002","hg19,16:g.14042002A>T",0.626,,,,,,
1110,1110,851,F,L,,,,,,,,,,,,,"cBioPortal,COSMIC","msk_access_2021, msk_impact_2017, nbl_msk_2023","Mixed Cancer Types, Neuroblastoma","hg19,16:14042006-14042006, hg38,16:13948149-13948149","hg19,16:g.14042006C>A, hg38,16:g.13948149C>A",0.132,autonomic_ganglia,neuroblastoma,,,,
1111,1111,851,F,V,,,,,,,,,,,,,COSMIC,,,"hg38,16:13948147-13948147","hg38,16:g.13948147T>G",0.217,breast,"carcinoma, ductal_carcinoma",1.19318452996e-05,0.0003504524021919,,
1112,1112,852,L,F,,,,,,,,,,,,,cBioPortal,acc_2019,Adenoid Cystic Carcinoma,"hg19,16:14042009-14042009","hg19,16:g.14042009G>C",0.342,,,3.9773766814e-06,,,
1113,1113,853,L,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 853-856, ELM",,,,,,,,,,,,,
1114,1114,854,K,R,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 853-856, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1115,1115,855,M,I,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 853-856, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14042018-14042018","hg19,16:g.14042018G>A",0.229,,,,,,
1116,1116,856,P,S,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 853-856, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,16:14042019-14042019, hg38,16:13948162-13948162","hg19,16:g.14042019C>T, hg38,16:g.13948162C>T",0.594,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,,,
1117,1117,857,G,,,,,,,,,,,,,,,,,,,,,,,,,
1118,1118,858,V,,,,,,,,,,,,,,,,,,,,,,,,,
1119,1119,859,N,Y,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1120,1120,860,A,D,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",mixed_pipseq_2017,Mixed Cancer Types,"hg19,16:14042032-14042032","hg19,16:g.14042032C>A",0.218,,,0.0006920360176907,0.0019754030459441,,
1121,1121,861,K,,,,Ubq,,,,,,,,,,,,,,,,,,,,,
1122,1122,862,N,,,,,,,,,,,,,,,,,,,,,,,,,
1123,1123,863,C,S,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1124,1124,864,R,C,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","coadread_tcga_pan_can_atlas_2018, glioma_mskcc_2019, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Diffuse Glioma, Mixed Cancer Types","hg19,16:14042043-14042043, hg38,16:13948186-13948186","hg19,16:g.14042043C>T, hg38,16:g.13948186C>T",0.116,"central_nervous_system, brain, large_intestine, large_intestine, colon","carcinoma, adenocarcinoma, glioma",1.19320351279e-05,,,
1125,1125,864,R,H,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1126,1126,864,R,L,,,,,,,,,,,,,cBioPortal,luad_tcga_pan_can_atlas_2018,Lung Adenocarcinoma,"hg19,16:14042044-14042044","hg19,16:g.14042044G>T",0.182,,,,,,
1127,1127,864,R,S,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:14042043-14042043, hg38,16:13948186-13948186","hg19,16:g.14042043C>A, hg38,16:g.13948186C>A",0.150,skin,malignant_melanoma,,,,
1128,1128,865,S,F,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1129,1129,866,L,F,,,,,,,,,,,,,cBioPortal,"cfdna_msk_2019, luad_mskcc_2023_met_organotropism, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14042051-14042051","hg19,16:g.14042051G>C",0.243,,,,,,
1130,1130,866,L,M,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:14042049-14042049","hg19,16:g.14042049T>A",0.231,,,,,,
1131,1131,867,M,I,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14042054-14042054","hg19,16:g.14042054G>A",0.105,,,,,,
1132,1132,868,H,P,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1133,1133,868,H,R,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1134,1134,868,H,Y,,,,,,,,,,,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14042055-14042055","hg19,16:g.14042055C>T",0.069,,,3.9773450426e-06,,,
1135,1135,869,H,,,,,,,,,,,,,,,,,,,,,,,,,
1136,1136,870,V,G,,,,,,,,,,,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,16:14042062-14042062, hg38,16:13948205-13948205","hg19,16:g.14042062T>G, hg38,16:g.13948205T>G",0.238,stomach,"carcinoma, adenocarcinoma",,,,
1137,1137,870,V,I,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","ccle_broad_2019, coadread_tcga_pan_can_atlas_2018, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14042061-14042061, hg38,16:13948204-13948204","hg19,16:g.14042061G>A, hg38,16:g.13948204G>A",0.201,"large_intestine, caecum","carcinoma, adenocarcinoma",2.386501945e-05,,,
1138,1138,871,K,N,,,,,,,,,,,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14042066-14042066, hg38,16:13948209-13948209","hg19,16:g.14042066G>C, hg38,16:g.13948209G>C",0.016,endometrium,"carcinoma, mixed_serous_and_endometrioid_carcinoma",,,,
1139,1139,871,K,R,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1140,1140,872,N,,,,,,,,,,,,,,,,,,,,,,,,,
1141,1141,873,I,M,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1142,1142,873,I,V,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","blca_bcan_hcrn_2022, mixed_pipseq_2017","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,16:14042070-14042070, hg38,16:13948213-13948213","hg19,16:g.14042070A>G, hg38,16:g.13948213A>G",0.097,prostate,carcinoma,0.0015471503002824,0.0052869609529269,,
1143,1143,874,A,T,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","msk_impact_2017, msk_met_2021, ucec_ccr_msk_2022, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14042073-14042073, hg38,16:13948216-13948216","hg19,16:g.14042073G>A, hg38,16:g.13948216G>A",0.229,endometrium,"carcinoma, endometrioid_carcinoma",,,,
1144,1144,874,A,V,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1145,1145,875,E,G,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",msk_impact_2017,Mixed Cancer Types,"hg19,16:14042077-14042077, hg38,16:13948220-13948220","hg19,16:g.14042077A>G, hg38,16:g.13948220A>G",0.292,"ovary, prostate, soft_tissue, striated_muscle, paratestis","carcinoma, carcinoma, serous_carcinoma, rhabdomyosarcoma, alveolar",0.0133044308328693,0.0119752850500032,,
1146,1146,876,L,,,,,,,,,,,,,,,,,,,,,,,,,
1147,1147,877,A,E,,,,,,,,,,,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,16:14042083-14042083, hg38,16:13948226-13948226","hg19,16:g.14042083C>A, hg38,16:g.13948226C>A",0.190,"autonomic_ganglia, retroperitoneum",neuroblastoma,,,,
1148,1148,877,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_msk_npjpo_2021, luad_mskcc_2020, luad_mskcc_2023_met_organotropism, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:14042083-14042083, hg38,16:13948226-13948226","hg19,16:g.14042083C>T, hg38,16:g.13948226C>T",0.090,lung,"carcinoma, adenocarcinoma",,,,
1149,1149,878,A,P,,,,,,,,,,,,,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,16:14042085-14042085","hg19,16:g.14042085G>C",0.036,,,,,,
1150,1150,878,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:14042086-14042086, hg38,16:13948229-13948229","hg19,16:g.14042086C>T, hg38,16:g.13948229C>T",0.030,large_intestine,"carcinoma, adenocarcinoma",3.9776930971e-06,,,
1151,1151,879,L,,,,,,,,,,,,,,,,,,,,,,,,,
1152,1152,880,S,,,,,,,,,,,,,,,,,,,,,,,,,
1153,1153,881,Q,E,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1154,1154,881,Q,R,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14042095-14042095","hg19,16:g.14042095A>G",0.037,,,,,,
1155,1155,882,D,,,,,,,,,,,,,,,,,,,,,,,,,
1156,1156,883,E,K,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","coad_silu_2022, coadread_dfci_2016","Colon Adenocarcinoma, Colorectal Adenocarcinoma","hg19,16:14042100-14042100, hg38,16:13948243-13948243","hg19,16:g.14042100G>A, hg38,16:g.13948243G>A",0.056,"large_intestine, large_intestine, rectum","carcinoma, adenocarcinoma",0.0005370099287169,0.0001274209989806,,
1157,1157,884,L,F,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1158,1158,885,T,A,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,"cBioPortal,COSMIC","egc_mskcc_2020, sclc_ucologne_2015","Esophagus/Stomach, Small Cell Lung Cancer","hg19,16:14042106-14042106, hg38,16:13948249-13948249","hg19,16:g.14042106A>G, hg38,16:g.13948249A>G",0.016,lung,"carcinoma, small_cell_carcinoma",,,,
1159,1159,885,T,M,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:14042107-14042107, hg38,16:13948250-13948250","hg19,16:g.14042107C>T, hg38,16:g.13948250C>T",0.060,endometrium,"carcinoma, endometrioid_carcinoma",3.9782311193e-06,,,
1160,1160,886,S,G,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,"cBioPortal,COSMIC","pancan_pcawg_2020, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:14042109-14042109, hg38,16:13948252-13948252","hg19,16:g.14042109A>G, hg38,16:g.13948252A>G",0.078,"endometrium, oesophagus","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,,,
1161,1161,886,S,N,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:14042110-14042110, hg38,16:13948253-13948253","hg19,16:g.14042110G>A, hg38,16:g.13948253G>A",0.079,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,3.18532203606e-05,,
1162,1162,887,I,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,,,,,,,,,,,,
1163,1163,888,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,,,,,,,,,,,,
1164,1164,889,G,E,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 883-889, ELM",,"cBioPortal,COSMIC",difg_glass_2019,Diffuse Glioma,"hg19,16:14042119-14042119, hg38,16:13948262-13948262","hg19,16:g.14042119G>A, hg38,16:g.13948262G>A",0.518,"central_nervous_system, brain",glioma,,,,
1165,1165,890,N,,,,,,,,,,,,,,,,,,,,,,,,,
1166,1166,891,A,,,,,,,,,,,,,,,,,,,,,,,,,
1167,1167,892,A,T,,,,,,,,,,,,,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1168,1168,892,A,V,,,,,,,,,,,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14042128-14042128","hg19,16:g.14042128C>T",0.013,,,,,,
1169,1169,893,N,D,,,,,,,,,,,,,"cBioPortal,Manual annotations from mutations_clinvar.csv",cellline_ccle_broad,Mixed Cancer Types,"hg19,16:14042130-14042130","hg19,16:g.14042130A>G",0.170,,,0.0002666666666667,0.0002229157378511,,
1170,1170,894,A,S,,,,,,,,,,,,,cBioPortal,paired_bladder_2022,Bladder/Urinary Tract,"hg19,16:14042133-14042133","hg19,16:g.14042133G>T",0.346,,,,,,
1171,1171,895,K,,,,,,,,,,,,,,,,,,,,,,,,,
1172,1172,896,Q,,,,,,,,,,,,,,,,,,,,,,,,,
1173,1173,897,L,,,,,,,,,,,,,,,,,,,,,,,,,
1174,1174,898,Y,C,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 898-902, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 898-901, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1175,1175,898,Y,N,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 898-902, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 898-901, ELM",,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,16:14042145-14042145","hg19,16:g.14042145T>A",0.181,,,,,,
1176,1176,899,D,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 898-902, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 898-901, ELM",,,,,,,,,,,,,
1177,1177,900,F,L,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 898-902, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 898-901, ELM",,"cBioPortal,COSMIC","brca_igr_2015, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Invasive Breast Carcinoma","hg19,16:14042153-14042153, hg38,16:13948296-13948296","hg19,16:g.14042153C>A, hg38,16:g.13948296C>A",0.323,"breast, endometrium","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, endometrioid_carcinoma",,,,
1178,1178,901,I,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 898-902, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 898-901, ELM",,,,,,,,,,,,,
1179,1179,902,H,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 898-902, ELM",,,,,,,,,,,,,
1180,1180,903,T,A,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1181,1181,903,T,S,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1182,1182,904,S,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 904-909, ELM",,,,,,,,,,,,,
1183,1183,905,F,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 904-909, ELM",,,,,,,,,,,,,
1184,1184,906,A,P,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 904-909, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,16:14042169-14042169, hg38,16:13948312-13948312","hg19,16:g.14042169G>C, hg38,16:g.13948312G>C",0.060,"urinary_tract, bladder",carcinoma,,,,
1185,1185,906,A,T,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 904-909, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,16:14042169-14042169","hg19,16:g.14042169G>A",0.014,,,,,,
1186,1186,907,E,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 904-909, ELM",,,,,,,,,,,,,
1187,1187,908,V,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 904-909, ELM",,,,,,,,,,,,,
1188,1188,909,V,A,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 904-909, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1189,1189,909,V,I,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 903-909, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 904-909, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:14042178-14042178, hg38,16:13948321-13948321","hg19,16:g.14042178G>A, hg38,16:g.13948321G>A",0.029,large_intestine,"carcinoma, adenocarcinoma",4.02045608054e-05,6.36902108146e-05,,
1190,1190,910,S,L,,,,,,,,,,,,,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:14042182-14042182, hg38,16:13948325-13948325","hg19,16:g.14042182C>T, hg38,16:g.13948325C>T",0.112,"breast, large_intestine, caecum","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",2.41470069785e-05,,,
1191,1191,911,K,I,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 911-915, ELM|di Lysine ER retrieving signal (TRG_ER_diLys_1), 911-916, ELM",,COSMIC,,,"hg38,16:13948328-13948328","hg38,16:g.13948328A>T",0.087,,malignant_melanoma,,,,
1192,1192,912,G,E,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 911-915, ELM|di Lysine ER retrieving signal (TRG_ER_diLys_1), 911-916, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1193,1193,912,G,R,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 911-915, ELM|di Lysine ER retrieving signal (TRG_ER_diLys_1), 911-916, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_clinvar.csv",esca_tcga_pan_can_atlas_2018,Esophageal Adenocarcinoma,"hg19,16:14042187-14042187, hg38,16:13948330-13948330","hg19,16:g.14042187G>A, hg38,16:g.13948330G>A",0.174,"soft_tissue, fat, retroperitoneum","liposarcoma, well_differentiated",0.0002140964322647,0.0001594998086002,,
1194,1194,913,K,R,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 911-915, ELM|di Lysine ER retrieving signal (TRG_ER_diLys_1), 911-916, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1195,1195,914,G,E,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 911-915, ELM|di Lysine ER retrieving signal (TRG_ER_diLys_1), 911-916, ELM",,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:14042194-14042194, hg38,16:13948337-13948337","hg19,16:g.14042194G>A, hg38,16:g.13948337G>A",0.019,lung,"carcinoma, adenocarcinoma",,,,
1196,1196,915,K,R,,,,,,,,,,,"USP7 binding motif (DOC_USP7_UBL2_3), 911-915, ELM|di Lysine ER retrieving signal (TRG_ER_diLys_1), 911-916, ELM",,Manual annotations from mutations_clinvar.csv,,,,,,,,,,,
1197,1197,916,K,,,,,,,,,,,,"di Lysine ER retrieving signal (TRG_ER_diLys_1), 911-916, ELM",,,,,,,,,,,,,
